Gene Symbol | Gene ID | Gene Info |
---|---|---|
Tead3
|
ENSMUSG00000002249.11 | TEA domain family member 3 |
Tead4
|
ENSMUSG00000030353.9 | TEA domain family member 4 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr17_28345881_28346331 | Tead3 | 4240 | 0.113089 | 0.86 | 3.7e-17 | Click! |
chr17_28345476_28345836 | Tead3 | 4690 | 0.109150 | 0.83 | 4.5e-15 | Click! |
chr17_28344321_28344512 | Tead3 | 5930 | 0.102125 | 0.80 | 3.6e-13 | Click! |
chr17_28344559_28344730 | Tead3 | 5702 | 0.103133 | 0.77 | 6.6e-12 | Click! |
chr17_28345231_28345460 | Tead3 | 5001 | 0.106966 | 0.77 | 8.6e-12 | Click! |
chr6_128300122_128300366 | Tead4 | 494 | 0.614861 | 0.72 | 6.2e-10 | Click! |
chr6_128300426_128300640 | Tead4 | 205 | 0.863149 | 0.72 | 7.7e-10 | Click! |
chr6_128300735_128301100 | Tead4 | 94 | 0.927913 | 0.67 | 2.8e-08 | Click! |
chr6_128275664_128275815 | Tead4 | 162 | 0.906250 | 0.61 | 6.0e-07 | Click! |
chr6_128299887_128300074 | Tead4 | 758 | 0.432766 | 0.60 | 1.1e-06 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr8_33992574_33993302 | 54.24 |
Gm45817 |
predicted gene 45817 |
5738 |
0.17 |
chr5_31630117_31630409 | 47.86 |
Rbks |
ribokinase |
10275 |
0.11 |
chr7_112656145_112656626 | 47.41 |
Gm45473 |
predicted gene 45473 |
3603 |
0.2 |
chr2_172862717_172863491 | 43.14 |
Gm22773 |
predicted gene, 22773 |
1237 |
0.55 |
chr5_103620590_103621012 | 41.68 |
Gm15844 |
predicted gene 15844 |
3670 |
0.17 |
chr8_61681266_61681542 | 40.39 |
Palld |
palladin, cytoskeletal associated protein |
78685 |
0.1 |
chr13_53033668_53033857 | 37.46 |
Gm48336 |
predicted gene, 48336 |
4844 |
0.22 |
chr1_55201883_55202252 | 36.97 |
Rftn2 |
raftlin family member 2 |
4422 |
0.16 |
chr13_63187189_63187410 | 35.73 |
Aopep |
aminopeptidase O |
3813 |
0.16 |
chr16_38793245_38793396 | 33.59 |
Upk1b |
uroplakin 1B |
7008 |
0.14 |
chr12_70712407_70712558 | 33.48 |
Gm32369 |
predicted gene, 32369 |
30632 |
0.14 |
chr14_66816904_66817095 | 33.42 |
Gm9130 |
predicted gene 9130 |
18621 |
0.16 |
chr17_49477498_49477655 | 33.25 |
Mocs1 |
molybdenum cofactor synthesis 1 |
25292 |
0.19 |
chr3_31022884_31023242 | 32.82 |
Prkci |
protein kinase C, iota |
8659 |
0.16 |
chr17_5463933_5464084 | 32.38 |
Gm8363 |
predicted gene 8363 |
18956 |
0.14 |
chr13_60365105_60365311 | 32.33 |
Gm10779 |
predicted gene 10779 |
33759 |
0.15 |
chr2_132006449_132006799 | 32.32 |
Rassf2 |
Ras association (RalGDS/AF-6) domain family member 2 |
14549 |
0.17 |
chr17_31896845_31897000 | 32.23 |
Gm50000 |
predicted gene, 50000 |
2256 |
0.22 |
chr8_47932403_47932817 | 31.94 |
n-R5s97 |
nuclear encoded rRNA 5S 97 |
33428 |
0.14 |
chr18_39738613_39738904 | 31.71 |
Gm50397 |
predicted gene, 50397 |
3799 |
0.27 |
chr5_24733276_24733452 | 31.65 |
Wdr86 |
WD repeat domain 86 |
2637 |
0.2 |
chr4_155133961_155134406 | 31.64 |
Morn1 |
MORN repeat containing 1 |
23493 |
0.14 |
chr3_145798795_145799202 | 31.21 |
Ddah1 |
dimethylarginine dimethylaminohydrolase 1 |
11481 |
0.21 |
chr6_37415105_37415455 | 31.14 |
Creb3l2 |
cAMP responsive element binding protein 3-like 2 |
26866 |
0.23 |
chr6_119196404_119196860 | 31.07 |
Cacna1c |
calcium channel, voltage-dependent, L type, alpha 1C subunit |
214 |
0.94 |
chr11_76120405_76120715 | 30.92 |
Vps53 |
VPS53 GARP complex subunit |
18188 |
0.16 |
chr4_43558412_43558599 | 30.75 |
Tln1 |
talin 1 |
45 |
0.93 |
chr12_4558721_4558885 | 30.72 |
Gm46332 |
predicted gene, 46332 |
5018 |
0.14 |
chr2_26309756_26310154 | 30.50 |
Gpsm1 |
G-protein signalling modulator 1 (AGS3-like, C. elegans) |
5560 |
0.11 |
chr3_149117420_149117674 | 30.20 |
Gm25127 |
predicted gene, 25127 |
88615 |
0.07 |
chr16_59566569_59566727 | 30.01 |
Crybg3 |
beta-gamma crystallin domain containing 3 |
10896 |
0.2 |
chr9_103861119_103861275 | 29.99 |
Gm5372 |
predicted gene 5372 |
26812 |
0.18 |
chr1_39186768_39187046 | 29.80 |
Mir6349 |
microRNA 6349 |
85 |
0.97 |
chr1_162074518_162074909 | 29.75 |
Gm37767 |
predicted gene, 37767 |
13755 |
0.19 |
chr16_44695627_44695867 | 29.00 |
Nepro |
nucleolus and neural progenitor protein |
28554 |
0.16 |
chr11_95982584_95982788 | 28.69 |
Igf2bp1 |
insulin-like growth factor 2 mRNA binding protein 1 |
75 |
0.94 |
chr2_167543915_167544428 | 28.67 |
Snai1 |
snail family zinc finger 1 |
5976 |
0.13 |
chr2_131061737_131061888 | 28.36 |
Adam33 |
a disintegrin and metallopeptidase domain 33 |
1701 |
0.24 |
chr3_159847707_159847886 | 28.22 |
Wls |
wntless WNT ligand secretion mediator |
655 |
0.77 |
chr11_84080427_84080578 | 28.06 |
Tada2a |
transcriptional adaptor 2A |
2454 |
0.25 |
chr7_130982381_130982744 | 27.90 |
Htra1 |
HtrA serine peptidase 1 |
168 |
0.96 |
chrX_12365711_12365881 | 27.88 |
Gm14635 |
predicted gene 14635 |
10800 |
0.27 |
chr10_39659287_39660442 | 27.77 |
2900078I11Rik |
RIKEN cDNA 2900078I11 gene |
1438 |
0.28 |
chr10_56980781_56980956 | 27.58 |
Gm36827 |
predicted gene, 36827 |
1364 |
0.54 |
chr16_78347693_78347860 | 27.33 |
Gm49590 |
predicted gene, 49590 |
4308 |
0.18 |
chr4_65912659_65912829 | 27.32 |
Trim32 |
tripartite motif-containing 32 |
307495 |
0.01 |
chr2_166427069_166427341 | 27.31 |
5031425F14Rik |
RIKEN cDNA 5031425F14 gene |
20246 |
0.19 |
chr8_11348742_11348915 | 26.94 |
Col4a1 |
collagen, type IV, alpha 1 |
36002 |
0.12 |
chr17_29451348_29451678 | 26.85 |
Gm36199 |
predicted gene, 36199 |
2161 |
0.2 |
chr15_25850601_25850949 | 26.85 |
Retreg1 |
reticulophagy regulator 1 |
7595 |
0.21 |
chr4_86527585_86527773 | 26.82 |
Saxo1 |
stabilizer of axonemal microtubules 1 |
11438 |
0.15 |
chr10_61848733_61848953 | 26.68 |
Col13a1 |
collagen, type XIII, alpha 1 |
368 |
0.88 |
chr5_132855695_132855874 | 26.67 |
Gm38373 |
predicted gene, 38373 |
59631 |
0.16 |
chr1_182399133_182399287 | 26.64 |
Gm5706 |
predicted gene 5706 |
5675 |
0.15 |
chr12_84805599_84805918 | 26.56 |
Ltbp2 |
latent transforming growth factor beta binding protein 2 |
6295 |
0.16 |
chr5_103620346_103620572 | 26.41 |
Gm15844 |
predicted gene 15844 |
4012 |
0.16 |
chr10_84388338_84388933 | 26.28 |
Nuak1 |
NUAK family, SNF1-like kinase, 1 |
3753 |
0.24 |
chr1_134803781_134803988 | 26.15 |
Ppp1r12b |
protein phosphatase 1, regulatory subunit 12B |
33 |
0.96 |
chr5_36255285_36255543 | 26.02 |
Sorcs2 |
sortilin-related VPS10 domain containing receptor 2 |
13065 |
0.21 |
chr16_55378800_55378951 | 25.94 |
Zpld1 |
zona pellucida like domain containing 1 |
80889 |
0.1 |
chr16_19946723_19946878 | 25.86 |
Klhl6 |
kelch-like 6 |
19519 |
0.17 |
chr2_137413565_137413716 | 25.84 |
Gm14055 |
predicted gene 14055 |
125137 |
0.06 |
chr11_62978995_62979146 | 25.76 |
Cdrt4os1 |
CMT1A duplicated region transcript 4, opposite strand 1 |
25058 |
0.12 |
chr10_41293067_41293416 | 25.72 |
Fig4 |
FIG4 phosphoinositide 5-phosphatase |
10019 |
0.16 |
chr18_5396168_5396377 | 25.54 |
Gm50065 |
predicted gene, 50065 |
25790 |
0.18 |
chr5_122520901_122521084 | 25.52 |
Gm22965 |
predicted gene, 22965 |
14203 |
0.09 |
chr9_79617333_79617783 | 25.42 |
Col12a1 |
collagen, type XII, alpha 1 |
4588 |
0.24 |
chr3_41295288_41295508 | 25.40 |
Gm16508 |
predicted gene 16508 |
4808 |
0.26 |
chr16_45873503_45873724 | 25.40 |
Phldb2 |
pleckstrin homology like domain, family B, member 2 |
28354 |
0.17 |
chr15_93630213_93630560 | 25.36 |
Prickle1 |
prickle planar cell polarity protein 1 |
34495 |
0.17 |
chr11_115841930_115842217 | 25.21 |
Llgl2 |
LLGL2 scribble cell polarity complex component |
7750 |
0.1 |
chr5_96616947_96617360 | 25.11 |
Fras1 |
Fraser extracellular matrix complex subunit 1 |
211 |
0.96 |
chr13_24565211_24565396 | 25.11 |
Ripor2 |
RHO family interacting cell polarization regulator 2 |
16886 |
0.18 |
chr9_62995124_62995631 | 25.02 |
Pias1 |
protein inhibitor of activated STAT 1 |
7453 |
0.21 |
chr5_24995828_24996139 | 24.99 |
Prkag2 |
protein kinase, AMP-activated, gamma 2 non-catalytic subunit |
230 |
0.93 |
chr2_35171698_35171898 | 24.98 |
Cntrl |
centriolin |
3450 |
0.2 |
chr15_33590796_33590947 | 24.98 |
Gm24476 |
predicted gene, 24476 |
1135 |
0.6 |
chr14_70170405_70170891 | 24.88 |
Pdlim2 |
PDZ and LIM domain 2 |
1338 |
0.31 |
chr6_71990158_71990323 | 24.60 |
Gm26628 |
predicted gene, 26628 |
26465 |
0.11 |
chr1_134082654_134083569 | 24.58 |
Btg2 |
BTG anti-proliferation factor 2 |
3991 |
0.15 |
chr5_124509823_124510249 | 24.57 |
Rilpl1 |
Rab interacting lysosomal protein-like 1 |
4623 |
0.11 |
chr10_63541782_63541976 | 24.55 |
Ctnna3 |
catenin (cadherin associated protein), alpha 3 |
32627 |
0.19 |
chr4_139250183_139250344 | 24.54 |
Capzb |
capping protein (actin filament) muscle Z-line, beta |
16880 |
0.13 |
chr18_61814562_61814715 | 24.52 |
Afap1l1 |
actin filament associated protein 1-like 1 |
27936 |
0.16 |
chr15_37197944_37198256 | 24.47 |
Gm8664 |
predicted gene 8664 |
15399 |
0.14 |
chr14_23494050_23494278 | 24.43 |
5430425E15Rik |
RIKEN cDNA 5430425E15 gene |
25498 |
0.21 |
chr2_164433438_164433839 | 24.39 |
Sdc4 |
syndecan 4 |
9548 |
0.08 |
chr2_170147589_170148059 | 24.35 |
Zfp217 |
zinc finger protein 217 |
279 |
0.95 |
chr1_23270993_23271181 | 24.26 |
Mir30a |
microRNA 30a |
1182 |
0.35 |
chr1_90100498_90100649 | 24.16 |
Iqca |
IQ motif containing with AAA domain |
10429 |
0.22 |
chr4_57560163_57560332 | 23.94 |
Pakap |
paralemmin A kinase anchor protein |
7912 |
0.27 |
chr8_36394574_36394785 | 23.93 |
Gm26150 |
predicted gene, 26150 |
11565 |
0.19 |
chr5_118841436_118841924 | 23.86 |
Gm43782 |
predicted gene 43782 |
35785 |
0.17 |
chr10_95864807_95865011 | 23.84 |
Gm47724 |
predicted gene, 47724 |
5890 |
0.14 |
chr17_32207642_32207826 | 23.59 |
Brd4 |
bromodomain containing 4 |
6726 |
0.13 |
chr1_89191219_89191400 | 23.53 |
Gm5259 |
predicted gene 5259 |
65672 |
0.11 |
chr13_24565549_24566352 | 23.53 |
Ripor2 |
RHO family interacting cell polarization regulator 2 |
16239 |
0.18 |
chr16_37809232_37809594 | 23.49 |
Fstl1 |
follistatin-like 1 |
6293 |
0.19 |
chr5_122519216_122519562 | 23.34 |
Gm22965 |
predicted gene, 22965 |
12600 |
0.09 |
chr19_34255239_34255724 | 23.30 |
Acta2 |
actin, alpha 2, smooth muscle, aorta |
109 |
0.96 |
chr5_140383662_140383903 | 23.11 |
Snx8 |
sorting nexin 8 |
1049 |
0.43 |
chr17_87350790_87351206 | 23.11 |
0610012D04Rik |
RIKEN cDNA 0610012D04 gene |
13464 |
0.13 |
chr17_79451641_79451795 | 23.04 |
Cdc42ep3 |
CDC42 effector protein (Rho GTPase binding) 3 |
96627 |
0.07 |
chr9_53325826_53325981 | 23.01 |
Exph5 |
exophilin 5 |
15181 |
0.18 |
chr11_105282557_105282801 | 22.97 |
Mrc2 |
mannose receptor, C type 2 |
9964 |
0.19 |
chr12_79896101_79896301 | 22.91 |
9430078K24Rik |
RIKEN cDNA 9430078K24 gene |
28532 |
0.18 |
chr16_15195208_15195760 | 22.89 |
Gm7731 |
predicted gene 7731 |
21844 |
0.2 |
chr2_113440320_113440655 | 22.82 |
Fmn1 |
formin 1 |
577 |
0.42 |
chr4_126495989_126496182 | 22.80 |
Gm12928 |
predicted gene 12928 |
18786 |
0.09 |
chr10_94096087_94096352 | 22.79 |
Gm18391 |
predicted gene, 18391 |
1921 |
0.25 |
chr12_70799430_70799753 | 22.68 |
Gm40437 |
predicted gene, 40437 |
25754 |
0.16 |
chr11_95225512_95225823 | 22.65 |
Gm11515 |
predicted gene 11515 |
35 |
0.97 |
chr17_88626334_88626813 | 22.63 |
Ston1 |
stonin 1 |
18 |
0.97 |
chr8_107821631_107821786 | 22.60 |
Gm23646 |
predicted gene, 23646 |
19249 |
0.18 |
chr5_36385148_36385489 | 22.57 |
Sorcs2 |
sortilin-related VPS10 domain containing receptor 2 |
12789 |
0.2 |
chr14_34592163_34592462 | 22.54 |
Opn4 |
opsin 4 (melanopsin) |
473 |
0.65 |
chr4_123593783_123593966 | 22.45 |
Macf1 |
microtubule-actin crosslinking factor 1 |
19869 |
0.15 |
chr12_57607743_57607909 | 22.44 |
4921518K17Rik |
RIKEN cDNA 4921518K17 gene |
10776 |
0.16 |
chr4_57743443_57743594 | 22.27 |
Pakap |
paralemmin A kinase anchor protein |
1423 |
0.43 |
chr2_4298295_4298485 | 22.26 |
Frmd4a |
FERM domain containing 4A |
2128 |
0.25 |
chr19_10909412_10909603 | 22.19 |
Zp1 |
zona pellucida glycoprotein 1 |
6791 |
0.1 |
chr2_163353818_163354318 | 22.19 |
Tox2 |
TOX high mobility group box family member 2 |
33690 |
0.12 |
chr13_68573041_68573220 | 22.18 |
Mtrr |
5-methyltetrahydrofolate-homocysteine methyltransferase reductase |
6914 |
0.16 |
chr3_37378419_37378715 | 22.17 |
Fgf2 |
fibroblast growth factor 2 |
2092 |
0.19 |
chr15_7222871_7223068 | 22.12 |
Egflam |
EGF-like, fibronectin type III and laminin G domains |
100 |
0.98 |
chr1_135324509_135324846 | 22.09 |
Lmod1 |
leiomodin 1 (smooth muscle) |
130 |
0.94 |
chr5_114413125_114413683 | 22.05 |
Mir7027 |
microRNA 7027 |
8936 |
0.13 |
chr16_90016108_90016386 | 21.97 |
Tiam1 |
T cell lymphoma invasion and metastasis 1 |
36167 |
0.18 |
chr15_96874188_96874389 | 21.95 |
Rpl10a-ps3 |
ribosomal protein L10A, pseudogene 3 |
49117 |
0.16 |
chr9_51397730_51398137 | 21.86 |
1810046K07Rik |
RIKEN cDNA 1810046K07 gene |
69009 |
0.1 |
chr14_25196881_25197203 | 21.85 |
4930572O13Rik |
RIKEN cDNA 4930572O13 gene |
53801 |
0.12 |
chr10_24446302_24446457 | 21.83 |
Gm15271 |
predicted gene 15271 |
1111 |
0.57 |
chr2_11375744_11376037 | 21.82 |
Gm37730 |
predicted gene, 37730 |
8439 |
0.1 |
chr15_67301869_67302358 | 21.81 |
1700012I11Rik |
RIKEN cDNA 1700012I11 gene |
75344 |
0.12 |
chr10_94990705_94991025 | 21.80 |
Gm48867 |
predicted gene, 48867 |
8577 |
0.22 |
chr4_43091306_43091457 | 21.78 |
Unc13b |
unc-13 homolog B |
23729 |
0.11 |
chr13_11432863_11433014 | 21.76 |
Gm25496 |
predicted gene, 25496 |
6040 |
0.29 |
chr5_92961952_92962161 | 21.74 |
Shroom3 |
shroom family member 3 |
17 |
0.98 |
chr2_144123477_144123676 | 21.74 |
Gm11687 |
predicted gene 11687 |
19797 |
0.16 |
chr13_46986313_46986464 | 21.73 |
Gm24769 |
predicted gene, 24769 |
5668 |
0.12 |
chr15_68401076_68401264 | 21.69 |
Gm20732 |
predicted gene 20732 |
37994 |
0.13 |
chr7_125632212_125632595 | 21.62 |
Gtf3c1 |
general transcription factor III C 1 |
17574 |
0.17 |
chr17_35720310_35720775 | 21.56 |
Ddr1 |
discoidin domain receptor family, member 1 |
15921 |
0.07 |
chr11_77836899_77837064 | 21.55 |
Myo18a |
myosin XVIIIA |
1106 |
0.46 |
chr11_76374871_76375078 | 21.43 |
Nxn |
nucleoredoxin |
24094 |
0.16 |
chr12_52879298_52879638 | 21.41 |
Akap6 |
A kinase (PRKA) anchor protein 6 |
83632 |
0.1 |
chr10_56980964_56981278 | 21.37 |
Gm36827 |
predicted gene, 36827 |
1111 |
0.62 |
chr7_36095842_36096014 | 21.36 |
Gm38991 |
predicted gene, 38991 |
1450 |
0.48 |
chr5_148950132_148950337 | 21.29 |
8430423G03Rik |
RIKEN cDNA 8430423G03 gene |
16 |
0.94 |
chr12_79859643_79860074 | 21.12 |
9430078K24Rik |
RIKEN cDNA 9430078K24 gene |
64875 |
0.11 |
chr10_116965373_116965543 | 21.12 |
D630029K05Rik |
RIKEN cDNA D630029K05 gene |
297 |
0.82 |
chr9_116234273_116234459 | 21.11 |
Gm31410 |
predicted gene, 31410 |
15564 |
0.19 |
chr9_51927950_51928376 | 21.03 |
Gm6980 |
predicted gene 6980 |
3498 |
0.2 |
chr19_54040338_54040692 | 20.90 |
Adra2a |
adrenergic receptor, alpha 2a |
3636 |
0.21 |
chr10_61759929_61760204 | 20.88 |
Mir5108 |
microRNA 5108 |
14671 |
0.14 |
chr1_151514240_151514401 | 20.76 |
Gm29072 |
predicted gene 29072 |
5096 |
0.13 |
chr2_108622854_108623077 | 20.68 |
Gm13913 |
predicted gene 13913 |
44576 |
0.16 |
chr8_123185685_123185914 | 20.61 |
Dpep1 |
dipeptidase 1 |
443 |
0.62 |
chr16_49954014_49954173 | 20.57 |
Cd47 |
CD47 antigen (Rh-related antigen, integrin-associated signal transducer) |
87260 |
0.1 |
chr7_30602566_30602860 | 20.57 |
Zbtb32 |
zinc finger and BTB domain containing 32 |
3804 |
0.07 |
chr7_143717942_143718103 | 20.57 |
Osbpl5 |
oxysterol binding protein-like 5 |
12903 |
0.12 |
chr16_11532671_11532865 | 20.50 |
Gm15897 |
predicted gene 15897 |
36462 |
0.19 |
chr3_57294019_57294225 | 20.49 |
Tm4sf1 |
transmembrane 4 superfamily member 1 |
419 |
0.84 |
chr5_135522543_135522694 | 20.45 |
Hip1 |
huntingtin interacting protein 1 |
22497 |
0.12 |
chr2_172413290_172413624 | 20.38 |
Cass4 |
Cas scaffolding protein family member 4 |
19556 |
0.11 |
chr1_189727337_189728664 | 20.38 |
Ptpn14 |
protein tyrosine phosphatase, non-receptor type 14 |
268 |
0.92 |
chr7_121941695_121941985 | 20.37 |
Cog7 |
component of oligomeric golgi complex 7 |
39854 |
0.11 |
chr13_93911107_93911258 | 20.35 |
Gm25534 |
predicted gene, 25534 |
12129 |
0.2 |
chr7_25902120_25902371 | 20.30 |
Cyp2b10 |
cytochrome P450, family 2, subfamily b, polypeptide 10 |
4569 |
0.13 |
chr6_122702513_122702906 | 20.26 |
Gm10224 |
predicted pseudogene 10224 |
3681 |
0.14 |
chr11_53308418_53308652 | 20.26 |
Hspa4 |
heat shock protein 4 |
8078 |
0.14 |
chr1_45864814_45864986 | 20.20 |
Gm5526 |
predicted pseudogene 5526 |
7146 |
0.14 |
chr11_84079993_84080159 | 20.16 |
Tada2a |
transcriptional adaptor 2A |
2880 |
0.23 |
chr10_9549977_9550305 | 20.11 |
Gm48755 |
predicted gene, 48755 |
2620 |
0.19 |
chr12_38843643_38844079 | 20.08 |
Etv1 |
ets variant 1 |
6463 |
0.21 |
chr8_11393018_11393578 | 20.05 |
Col4a2 |
collagen, type IV, alpha 2 |
11610 |
0.16 |
chr6_101484683_101484872 | 20.04 |
Gm44169 |
predicted gene, 44169 |
34878 |
0.17 |
chr14_54577785_54578159 | 20.03 |
Ajuba |
ajuba LIM protein |
414 |
0.66 |
chr10_94789237_94789533 | 20.02 |
Gm48689 |
predicted gene, 48689 |
2224 |
0.27 |
chr18_83827448_83827828 | 20.01 |
Gm50419 |
predicted gene, 50419 |
32 |
0.98 |
chr2_35432055_35432360 | 20.00 |
Ggta1 |
glycoprotein galactosyltransferase alpha 1, 3 |
426 |
0.77 |
chr14_76681991_76682287 | 20.00 |
1700108F19Rik |
RIKEN cDNA 1700108F19 gene |
385 |
0.88 |
chr11_31564815_31565008 | 19.97 |
Bod1 |
biorientation of chromosomes in cell division 1 |
106816 |
0.07 |
chr6_112281073_112281282 | 19.96 |
Lmcd1 |
LIM and cysteine-rich domains 1 |
7419 |
0.16 |
chr3_107986374_107986583 | 19.94 |
Gstm2 |
glutathione S-transferase, mu 2 |
25 |
0.93 |
chr1_55865349_55865539 | 19.92 |
9130227L01Rik |
RIKEN cDNA 9130227L01 gene |
65797 |
0.12 |
chr15_96658045_96658257 | 19.92 |
Gm22045 |
predicted gene, 22045 |
13642 |
0.17 |
chr10_95388742_95389022 | 19.87 |
Socs2 |
suppressor of cytokine signaling 2 |
4085 |
0.16 |
chr13_5604202_5604519 | 19.86 |
Gm35330 |
predicted gene, 35330 |
33232 |
0.23 |
chr8_61574680_61574831 | 19.82 |
Palld |
palladin, cytoskeletal associated protein |
16384 |
0.25 |
chr10_4116803_4116954 | 19.81 |
Gm25515 |
predicted gene, 25515 |
12565 |
0.21 |
chr16_32859311_32859478 | 19.81 |
Rubcn |
RUN domain and cysteine-rich domain containing, Beclin 1-interacting protein |
8944 |
0.14 |
chr10_98292387_98292541 | 19.78 |
Gm48687 |
predicted gene, 48687 |
8555 |
0.28 |
chr4_154213598_154213966 | 19.78 |
Gm13132 |
predicted gene 13132 |
6759 |
0.16 |
chr11_20955656_20955883 | 19.73 |
Gm23681 |
predicted gene, 23681 |
18068 |
0.21 |
chr4_102635313_102635490 | 19.73 |
Pde4b |
phosphodiesterase 4B, cAMP specific |
45558 |
0.17 |
chr11_79752396_79752576 | 19.67 |
Mir365-2 |
microRNA 365-2 |
26086 |
0.12 |
chr11_67835810_67835961 | 19.61 |
Dhrs7c |
dehydrogenase/reductase (SDR family) member 7C |
37598 |
0.12 |
chr1_192822583_192823027 | 19.54 |
Gm38360 |
predicted gene, 38360 |
1678 |
0.27 |
chr9_47675484_47675635 | 19.49 |
Gm47198 |
predicted gene, 47198 |
95582 |
0.07 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
11.9 | 35.8 | GO:0048769 | sarcomerogenesis(GO:0048769) |
10.9 | 43.5 | GO:0086045 | membrane depolarization during AV node cell action potential(GO:0086045) |
8.7 | 26.1 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
8.7 | 43.5 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
8.3 | 25.0 | GO:0061355 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
8.3 | 24.9 | GO:0051410 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
8.1 | 48.8 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
8.0 | 48.1 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
7.9 | 23.8 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
7.8 | 47.0 | GO:0014721 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) |
7.6 | 15.2 | GO:0021823 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) postnatal olfactory bulb interneuron migration(GO:0021827) |
7.2 | 57.9 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
7.0 | 21.1 | GO:0007525 | somatic muscle development(GO:0007525) |
6.7 | 13.4 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
6.6 | 19.9 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) |
6.5 | 19.6 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
6.5 | 6.5 | GO:0060686 | negative regulation of prostatic bud formation(GO:0060686) |
6.4 | 12.7 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
6.2 | 18.5 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
6.1 | 30.4 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) |
5.6 | 22.4 | GO:1904849 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
5.4 | 16.3 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
5.2 | 25.8 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
5.1 | 5.1 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
4.9 | 14.7 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
4.9 | 9.8 | GO:0021564 | vagus nerve development(GO:0021564) |
4.9 | 14.6 | GO:0048022 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
4.6 | 4.6 | GO:0061643 | chemorepulsion of axon(GO:0061643) |
4.6 | 18.4 | GO:0046959 | habituation(GO:0046959) |
4.5 | 4.5 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) striated muscle myosin thick filament assembly(GO:0071688) |
4.5 | 18.0 | GO:0044849 | estrous cycle(GO:0044849) |
4.5 | 17.9 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
4.5 | 13.4 | GO:0032910 | transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) |
4.5 | 26.7 | GO:0045630 | positive regulation of T-helper 2 cell differentiation(GO:0045630) |
4.4 | 17.8 | GO:0072093 | metanephric renal vesicle formation(GO:0072093) |
4.4 | 4.4 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
4.3 | 13.0 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
4.3 | 12.9 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
4.3 | 12.9 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
4.3 | 21.4 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
4.2 | 8.5 | GO:0090154 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
4.2 | 4.2 | GO:1902338 | negative regulation of apoptotic process involved in morphogenesis(GO:1902338) |
4.2 | 8.3 | GO:0003163 | sinoatrial node development(GO:0003163) |
4.1 | 8.2 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
4.1 | 4.1 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
4.0 | 12.1 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
4.0 | 12.0 | GO:0048865 | stem cell fate commitment(GO:0048865) |
4.0 | 12.0 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
4.0 | 12.0 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
4.0 | 27.9 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
4.0 | 27.7 | GO:0071340 | skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
3.9 | 7.8 | GO:1902744 | negative regulation of lamellipodium organization(GO:1902744) |
3.9 | 11.7 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
3.9 | 30.9 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
3.9 | 15.4 | GO:1904395 | regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904393) positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
3.8 | 11.5 | GO:0032474 | otolith morphogenesis(GO:0032474) |
3.8 | 11.5 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
3.7 | 11.2 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
3.7 | 3.7 | GO:0003166 | bundle of His development(GO:0003166) |
3.6 | 21.7 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
3.6 | 7.2 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
3.6 | 18.0 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
3.6 | 3.6 | GO:1904684 | negative regulation of metalloendopeptidase activity(GO:1904684) negative regulation of metallopeptidase activity(GO:1905049) |
3.6 | 10.8 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
3.6 | 7.2 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
3.6 | 10.7 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
3.6 | 3.6 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
3.5 | 10.6 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
3.5 | 10.4 | GO:2000974 | negative regulation of pro-B cell differentiation(GO:2000974) |
3.5 | 13.8 | GO:0051890 | regulation of cardioblast differentiation(GO:0051890) |
3.4 | 20.6 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
3.4 | 6.8 | GO:0032439 | endosome localization(GO:0032439) |
3.4 | 17.0 | GO:0060509 | Type I pneumocyte differentiation(GO:0060509) |
3.4 | 6.8 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
3.4 | 10.2 | GO:0051794 | regulation of catagen(GO:0051794) |
3.3 | 10.0 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
3.3 | 10.0 | GO:0048320 | axial mesoderm formation(GO:0048320) |
3.3 | 13.2 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
3.3 | 26.4 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
3.3 | 3.3 | GO:2000591 | positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
3.3 | 9.8 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
3.2 | 16.0 | GO:1904424 | regulation of GTP binding(GO:1904424) |
3.2 | 9.6 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
3.2 | 15.9 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
3.2 | 3.2 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
3.2 | 22.2 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
3.1 | 18.6 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
3.1 | 9.3 | GO:0030421 | defecation(GO:0030421) |
3.1 | 9.3 | GO:0021550 | medulla oblongata development(GO:0021550) |
3.1 | 12.3 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
3.1 | 12.2 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
3.1 | 9.2 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
3.0 | 48.3 | GO:0006907 | pinocytosis(GO:0006907) |
3.0 | 15.1 | GO:0042118 | endothelial cell activation(GO:0042118) |
3.0 | 29.9 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
3.0 | 3.0 | GO:0072173 | metanephric tubule morphogenesis(GO:0072173) |
3.0 | 6.0 | GO:0032594 | protein transport within lipid bilayer(GO:0032594) |
3.0 | 3.0 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) |
3.0 | 3.0 | GO:0070673 | response to interleukin-18(GO:0070673) cellular response to interleukin-18(GO:0071351) |
2.9 | 5.8 | GO:0061642 | chemoattraction of axon(GO:0061642) |
2.9 | 5.8 | GO:1904139 | microglial cell migration(GO:1904124) regulation of microglial cell migration(GO:1904139) |
2.8 | 5.7 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
2.8 | 14.2 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
2.8 | 34.0 | GO:1902287 | semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
2.8 | 16.8 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
2.8 | 27.9 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
2.8 | 2.8 | GO:0061055 | myotome development(GO:0061055) |
2.8 | 22.2 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
2.8 | 8.3 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
2.7 | 8.2 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
2.7 | 2.7 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
2.7 | 10.7 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
2.7 | 5.3 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
2.6 | 10.6 | GO:0002159 | desmosome assembly(GO:0002159) |
2.6 | 7.9 | GO:1903849 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
2.6 | 10.4 | GO:0060681 | branch elongation involved in ureteric bud branching(GO:0060681) |
2.6 | 5.2 | GO:0048696 | regulation of collateral sprouting in absence of injury(GO:0048696) |
2.6 | 5.2 | GO:2000321 | positive regulation of T-helper 17 cell differentiation(GO:2000321) |
2.6 | 5.2 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
2.6 | 5.1 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
2.6 | 2.6 | GO:0060066 | oviduct development(GO:0060066) |
2.6 | 5.1 | GO:0090135 | actin filament branching(GO:0090135) |
2.6 | 10.2 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
2.5 | 7.6 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
2.5 | 7.6 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
2.5 | 7.6 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
2.5 | 2.5 | GO:0090579 | transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
2.5 | 5.0 | GO:2000977 | regulation of forebrain neuron differentiation(GO:2000977) |
2.5 | 9.9 | GO:0071694 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
2.5 | 9.9 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
2.5 | 4.9 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
2.4 | 14.3 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
2.4 | 9.6 | GO:0098915 | membrane repolarization during ventricular cardiac muscle cell action potential(GO:0098915) |
2.4 | 4.8 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
2.4 | 9.6 | GO:0050955 | thermoception(GO:0050955) |
2.4 | 35.7 | GO:0036303 | lymphangiogenesis(GO:0001946) lymph vessel morphogenesis(GO:0036303) |
2.4 | 2.4 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
2.4 | 26.1 | GO:0003338 | metanephros morphogenesis(GO:0003338) |
2.4 | 9.5 | GO:0046449 | creatinine metabolic process(GO:0046449) cellular lactam metabolic process(GO:0072338) |
2.4 | 9.5 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
2.4 | 21.3 | GO:0035313 | wound healing, spreading of epidermal cells(GO:0035313) |
2.4 | 4.7 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
2.4 | 2.4 | GO:1900242 | regulation of synaptic vesicle endocytosis(GO:1900242) |
2.4 | 16.5 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
2.3 | 7.0 | GO:0070836 | caveola assembly(GO:0070836) |
2.3 | 11.7 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
2.3 | 9.3 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
2.3 | 4.7 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
2.3 | 11.6 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
2.3 | 4.6 | GO:2000645 | negative regulation of receptor catabolic process(GO:2000645) |
2.3 | 9.2 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
2.3 | 13.8 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
2.3 | 11.4 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
2.3 | 2.3 | GO:0010911 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
2.3 | 9.0 | GO:0044598 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
2.2 | 18.0 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
2.2 | 28.9 | GO:0003334 | keratinocyte development(GO:0003334) |
2.2 | 15.4 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
2.2 | 10.9 | GO:0090383 | phagosome acidification(GO:0090383) |
2.2 | 15.3 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
2.2 | 15.2 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
2.2 | 6.5 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
2.2 | 4.3 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
2.2 | 4.3 | GO:0072361 | regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter(GO:0072361) |
2.2 | 6.5 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
2.2 | 10.8 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
2.2 | 10.8 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
2.1 | 2.1 | GO:0033122 | negative regulation of purine nucleotide catabolic process(GO:0033122) |
2.1 | 10.6 | GO:0051775 | response to redox state(GO:0051775) |
2.1 | 4.2 | GO:2000668 | dendritic cell apoptotic process(GO:0097048) regulation of dendritic cell apoptotic process(GO:2000668) |
2.1 | 6.3 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
2.1 | 12.7 | GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
2.1 | 4.2 | GO:1904016 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
2.1 | 8.4 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
2.1 | 12.5 | GO:1901550 | regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
2.1 | 14.6 | GO:0017014 | protein nitrosylation(GO:0017014) |
2.1 | 6.2 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
2.1 | 4.2 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
2.0 | 8.2 | GO:0015705 | iodide transport(GO:0015705) |
2.0 | 10.2 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
2.0 | 8.2 | GO:0086023 | adrenergic receptor signaling pathway involved in heart process(GO:0086023) |
2.0 | 8.1 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
2.0 | 10.2 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
2.0 | 2.0 | GO:0032959 | inositol trisphosphate biosynthetic process(GO:0032959) |
2.0 | 18.2 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
2.0 | 8.0 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
2.0 | 4.0 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
2.0 | 4.0 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
2.0 | 6.0 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
2.0 | 25.8 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) |
2.0 | 7.9 | GO:0001945 | lymph vessel development(GO:0001945) |
2.0 | 9.9 | GO:2000810 | regulation of bicellular tight junction assembly(GO:2000810) |
2.0 | 17.8 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
2.0 | 13.8 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
2.0 | 19.7 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
2.0 | 3.9 | GO:0032079 | positive regulation of endodeoxyribonuclease activity(GO:0032079) |
2.0 | 3.9 | GO:0003383 | apical constriction(GO:0003383) |
2.0 | 5.9 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
2.0 | 5.9 | GO:0061042 | vascular wound healing(GO:0061042) |
2.0 | 9.8 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
1.9 | 5.8 | GO:0000820 | regulation of glutamine family amino acid metabolic process(GO:0000820) |
1.9 | 7.8 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
1.9 | 5.8 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
1.9 | 5.8 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
1.9 | 5.8 | GO:0060155 | platelet dense granule organization(GO:0060155) |
1.9 | 7.7 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
1.9 | 7.7 | GO:0038089 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
1.9 | 1.9 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
1.9 | 11.5 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
1.9 | 7.7 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
1.9 | 9.6 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
1.9 | 9.5 | GO:0072540 | T-helper 17 cell lineage commitment(GO:0072540) |
1.9 | 7.6 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
1.9 | 19.0 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
1.9 | 3.8 | GO:0007386 | compartment pattern specification(GO:0007386) |
1.9 | 3.8 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
1.9 | 1.9 | GO:0060978 | angiogenesis involved in coronary vascular morphogenesis(GO:0060978) |
1.9 | 13.2 | GO:0001778 | plasma membrane repair(GO:0001778) |
1.9 | 3.7 | GO:0010694 | positive regulation of alkaline phosphatase activity(GO:0010694) |
1.9 | 18.7 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
1.8 | 5.5 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) |
1.8 | 5.5 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
1.8 | 9.1 | GO:0043149 | contractile actin filament bundle assembly(GO:0030038) stress fiber assembly(GO:0043149) |
1.8 | 5.5 | GO:0031087 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
1.8 | 87.0 | GO:0007044 | cell-substrate junction assembly(GO:0007044) |
1.8 | 5.4 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
1.8 | 9.0 | GO:0035280 | miRNA loading onto RISC involved in gene silencing by miRNA(GO:0035280) |
1.8 | 10.8 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
1.8 | 5.4 | GO:0061623 | galactose catabolic process via UDP-galactose(GO:0033499) glycolytic process from galactose(GO:0061623) |
1.8 | 3.6 | GO:0031642 | negative regulation of myelination(GO:0031642) |
1.8 | 12.4 | GO:0086069 | bundle of His cell to Purkinje myocyte communication(GO:0086069) |
1.8 | 1.8 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
1.7 | 5.2 | GO:0015817 | histidine transport(GO:0015817) |
1.7 | 3.5 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
1.7 | 1.7 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
1.7 | 5.2 | GO:1902075 | cellular response to salt(GO:1902075) |
1.7 | 8.6 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
1.7 | 6.9 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
1.7 | 10.3 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
1.7 | 5.2 | GO:0003207 | cardiac chamber formation(GO:0003207) |
1.7 | 8.5 | GO:0042045 | epithelial fluid transport(GO:0042045) |
1.7 | 1.7 | GO:0010159 | specification of organ position(GO:0010159) |
1.7 | 6.8 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
1.7 | 3.4 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
1.7 | 3.4 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
1.7 | 1.7 | GO:0022009 | central nervous system vasculogenesis(GO:0022009) |
1.7 | 6.7 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
1.7 | 5.0 | GO:0071313 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
1.7 | 8.3 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
1.7 | 1.7 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
1.7 | 10.0 | GO:0070995 | NADPH oxidation(GO:0070995) |
1.7 | 6.7 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
1.6 | 3.3 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
1.6 | 6.6 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
1.6 | 29.4 | GO:0001937 | negative regulation of endothelial cell proliferation(GO:0001937) |
1.6 | 21.1 | GO:0014850 | response to muscle activity(GO:0014850) |
1.6 | 1.6 | GO:0060662 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
1.6 | 4.9 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
1.6 | 6.4 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
1.6 | 1.6 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
1.6 | 3.2 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
1.6 | 1.6 | GO:0032097 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
1.6 | 8.0 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) |
1.6 | 4.8 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
1.6 | 9.5 | GO:0048251 | elastic fiber assembly(GO:0048251) |
1.6 | 4.8 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
1.6 | 6.3 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
1.6 | 3.2 | GO:0060318 | definitive erythrocyte differentiation(GO:0060318) |
1.6 | 30.0 | GO:0014829 | vascular smooth muscle contraction(GO:0014829) |
1.6 | 6.3 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
1.6 | 1.6 | GO:0072076 | nephrogenic mesenchyme development(GO:0072076) |
1.6 | 1.6 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
1.6 | 4.7 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
1.5 | 4.6 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
1.5 | 13.9 | GO:0060742 | epithelial cell differentiation involved in prostate gland development(GO:0060742) |
1.5 | 6.1 | GO:0002072 | optic cup morphogenesis involved in camera-type eye development(GO:0002072) |
1.5 | 3.1 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
1.5 | 6.1 | GO:0018103 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
1.5 | 4.5 | GO:1901798 | positive regulation of signal transduction by p53 class mediator(GO:1901798) |
1.5 | 4.5 | GO:0038030 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
1.5 | 3.0 | GO:0046061 | dATP catabolic process(GO:0046061) |
1.5 | 3.0 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
1.5 | 3.0 | GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) |
1.5 | 7.5 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
1.5 | 3.0 | GO:0001705 | ectoderm formation(GO:0001705) |
1.5 | 4.4 | GO:0052490 | negative regulation by symbiont of host apoptotic process(GO:0033668) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
1.5 | 5.9 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
1.5 | 10.3 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
1.5 | 19.1 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
1.5 | 4.4 | GO:0015819 | lysine transport(GO:0015819) |
1.5 | 5.8 | GO:0030091 | protein repair(GO:0030091) |
1.5 | 10.2 | GO:0060644 | mammary gland epithelial cell differentiation(GO:0060644) |
1.5 | 4.4 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
1.5 | 11.6 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
1.5 | 1.5 | GO:0060982 | coronary artery morphogenesis(GO:0060982) |
1.4 | 24.6 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
1.4 | 30.3 | GO:0006110 | regulation of glycolytic process(GO:0006110) |
1.4 | 4.3 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
1.4 | 4.3 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
1.4 | 4.3 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
1.4 | 12.9 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
1.4 | 7.2 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
1.4 | 24.3 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
1.4 | 5.7 | GO:0098728 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
1.4 | 2.9 | GO:0035993 | deltoid tuberosity development(GO:0035993) |
1.4 | 4.3 | GO:0036506 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
1.4 | 2.8 | GO:1902805 | positive regulation of synaptic vesicle transport(GO:1902805) |
1.4 | 4.3 | GO:0072539 | T-helper 17 cell differentiation(GO:0072539) |
1.4 | 4.3 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
1.4 | 5.6 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
1.4 | 4.2 | GO:0007097 | nuclear migration(GO:0007097) |
1.4 | 5.6 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
1.4 | 4.2 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
1.4 | 1.4 | GO:0070640 | vitamin D3 metabolic process(GO:0070640) |
1.4 | 4.2 | GO:0010979 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
1.4 | 1.4 | GO:0060253 | negative regulation of glial cell proliferation(GO:0060253) |
1.4 | 25.1 | GO:0045214 | sarcomere organization(GO:0045214) |
1.4 | 5.6 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
1.4 | 1.4 | GO:1900221 | regulation of beta-amyloid clearance(GO:1900221) |
1.4 | 8.4 | GO:0032324 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
1.4 | 2.8 | GO:0032819 | positive regulation of natural killer cell proliferation(GO:0032819) |
1.4 | 11.1 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
1.4 | 4.2 | GO:0031280 | negative regulation of cyclase activity(GO:0031280) |
1.4 | 2.8 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
1.4 | 5.5 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
1.4 | 13.7 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
1.4 | 5.5 | GO:0010991 | regulation of SMAD protein complex assembly(GO:0010990) negative regulation of SMAD protein complex assembly(GO:0010991) |
1.4 | 8.2 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
1.4 | 2.7 | GO:0061098 | positive regulation of protein tyrosine kinase activity(GO:0061098) |
1.4 | 1.4 | GO:0010700 | negative regulation of norepinephrine secretion(GO:0010700) |
1.4 | 6.8 | GO:0015886 | heme transport(GO:0015886) |
1.4 | 6.8 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
1.4 | 27.0 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
1.3 | 1.3 | GO:0032741 | positive regulation of interleukin-18 production(GO:0032741) |
1.3 | 1.3 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) |
1.3 | 1.3 | GO:0038086 | VEGF-activated platelet-derived growth factor receptor signaling pathway(GO:0038086) positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway(GO:0038091) |
1.3 | 5.3 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
1.3 | 5.3 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
1.3 | 2.7 | GO:0002840 | T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) |
1.3 | 16.0 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
1.3 | 1.3 | GO:0097242 | beta-amyloid clearance(GO:0097242) |
1.3 | 9.3 | GO:0060068 | vagina development(GO:0060068) |
1.3 | 4.0 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
1.3 | 11.9 | GO:0019321 | pentose metabolic process(GO:0019321) |
1.3 | 4.0 | GO:0080154 | regulation of fertilization(GO:0080154) |
1.3 | 11.9 | GO:0060065 | uterus development(GO:0060065) |
1.3 | 6.5 | GO:0071318 | cellular response to ATP(GO:0071318) |
1.3 | 5.2 | GO:0030917 | midbrain-hindbrain boundary development(GO:0030917) |
1.3 | 2.6 | GO:0051541 | elastin metabolic process(GO:0051541) |
1.3 | 6.5 | GO:0099515 | actin filament-based transport(GO:0099515) |
1.3 | 2.6 | GO:0046878 | positive regulation of saliva secretion(GO:0046878) |
1.3 | 1.3 | GO:2000054 | regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000053) negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
1.3 | 1.3 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
1.3 | 3.9 | GO:0019287 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
1.3 | 3.9 | GO:0002901 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
1.3 | 3.9 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
1.3 | 7.7 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
1.3 | 1.3 | GO:1903818 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
1.3 | 2.5 | GO:1901201 | regulation of extracellular matrix assembly(GO:1901201) |
1.3 | 2.5 | GO:0071679 | commissural neuron axon guidance(GO:0071679) |
1.3 | 8.8 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
1.3 | 2.5 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
1.2 | 7.5 | GO:0032060 | bleb assembly(GO:0032060) |
1.2 | 5.0 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
1.2 | 3.7 | GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) |
1.2 | 2.5 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
1.2 | 4.9 | GO:0044026 | DNA hypermethylation(GO:0044026) |
1.2 | 4.9 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) |
1.2 | 8.6 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
1.2 | 2.4 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
1.2 | 1.2 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
1.2 | 2.4 | GO:0060347 | heart trabecula formation(GO:0060347) |
1.2 | 47.3 | GO:0015914 | phospholipid transport(GO:0015914) |
1.2 | 3.6 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
1.2 | 6.0 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
1.2 | 2.4 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
1.2 | 3.6 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
1.2 | 7.1 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
1.2 | 7.1 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
1.2 | 4.7 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
1.2 | 8.3 | GO:0030575 | nuclear body organization(GO:0030575) |
1.2 | 4.7 | GO:0042738 | exogenous drug catabolic process(GO:0042738) |
1.2 | 11.8 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
1.2 | 3.5 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
1.2 | 4.7 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
1.2 | 2.4 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
1.2 | 2.3 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
1.2 | 5.9 | GO:0051496 | positive regulation of stress fiber assembly(GO:0051496) |
1.2 | 18.7 | GO:0017144 | drug metabolic process(GO:0017144) |
1.2 | 2.3 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
1.2 | 3.5 | GO:0034473 | U1 snRNA 3'-end processing(GO:0034473) U5 snRNA 3'-end processing(GO:0034476) |
1.2 | 1.2 | GO:0006407 | rRNA export from nucleus(GO:0006407) |
1.2 | 1.2 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
1.2 | 5.8 | GO:1901563 | cellular response to camptothecin(GO:0072757) response to camptothecin(GO:1901563) |
1.2 | 3.5 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
1.2 | 3.5 | GO:0007412 | axon target recognition(GO:0007412) |
1.2 | 4.6 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
1.2 | 9.2 | GO:0002042 | cell migration involved in sprouting angiogenesis(GO:0002042) |
1.1 | 4.6 | GO:0030222 | eosinophil differentiation(GO:0030222) |
1.1 | 1.1 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
1.1 | 1.1 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
1.1 | 2.3 | GO:0051105 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
1.1 | 3.4 | GO:0001880 | Mullerian duct regression(GO:0001880) |
1.1 | 2.3 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
1.1 | 2.3 | GO:0090205 | positive regulation of cholesterol biosynthetic process(GO:0045542) positive regulation of cholesterol metabolic process(GO:0090205) |
1.1 | 2.3 | GO:0032960 | regulation of inositol trisphosphate biosynthetic process(GO:0032960) positive regulation of inositol trisphosphate biosynthetic process(GO:0032962) |
1.1 | 1.1 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
1.1 | 3.4 | GO:0045343 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) positive regulation of MHC class I biosynthetic process(GO:0045345) |
1.1 | 15.8 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
1.1 | 3.4 | GO:0030576 | Cajal body organization(GO:0030576) |
1.1 | 3.4 | GO:0046049 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
1.1 | 1.1 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
1.1 | 2.2 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
1.1 | 5.6 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
1.1 | 1.1 | GO:0071336 | regulation of hair follicle cell proliferation(GO:0071336) |
1.1 | 3.4 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
1.1 | 5.6 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
1.1 | 4.5 | GO:1901888 | regulation of cell junction assembly(GO:1901888) |
1.1 | 5.6 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
1.1 | 11.1 | GO:0048268 | clathrin coat assembly(GO:0048268) |
1.1 | 11.1 | GO:0070527 | platelet aggregation(GO:0070527) |
1.1 | 5.6 | GO:1901317 | regulation of sperm motility(GO:1901317) |
1.1 | 12.2 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
1.1 | 1.1 | GO:0051451 | myoblast migration(GO:0051451) |
1.1 | 3.3 | GO:2000409 | positive regulation of T cell extravasation(GO:2000409) |
1.1 | 3.3 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
1.1 | 31.8 | GO:0005978 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
1.1 | 9.9 | GO:0031507 | heterochromatin assembly(GO:0031507) |
1.1 | 2.2 | GO:0034137 | positive regulation of toll-like receptor 2 signaling pathway(GO:0034137) |
1.1 | 7.7 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) |
1.1 | 4.4 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
1.1 | 1.1 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
1.1 | 8.7 | GO:0001553 | luteinization(GO:0001553) |
1.1 | 2.2 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
1.1 | 6.5 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
1.1 | 1.1 | GO:0060600 | dichotomous subdivision of an epithelial terminal unit(GO:0060600) |
1.1 | 1.1 | GO:0072538 | T-helper 17 type immune response(GO:0072538) |
1.1 | 3.2 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
1.1 | 13.0 | GO:0014898 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
1.1 | 5.4 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
1.1 | 7.5 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
1.1 | 6.4 | GO:0051764 | actin crosslink formation(GO:0051764) |
1.1 | 3.2 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
1.1 | 4.3 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
1.1 | 5.3 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
1.1 | 5.3 | GO:0043206 | extracellular fibril organization(GO:0043206) |
1.1 | 14.9 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
1.1 | 2.1 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
1.1 | 5.3 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
1.1 | 8.5 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
1.1 | 4.2 | GO:0018101 | protein citrullination(GO:0018101) |
1.1 | 1.1 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
1.1 | 5.3 | GO:0035459 | cargo loading into vesicle(GO:0035459) |
1.1 | 1.1 | GO:0060157 | urinary bladder development(GO:0060157) |
1.1 | 1.1 | GO:1903392 | negative regulation of adherens junction organization(GO:1903392) |
1.0 | 2.1 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
1.0 | 8.4 | GO:0046838 | phosphorylated carbohydrate dephosphorylation(GO:0046838) inositol phosphate dephosphorylation(GO:0046855) |
1.0 | 1.0 | GO:0008354 | germ cell migration(GO:0008354) |
1.0 | 3.1 | GO:1905216 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
1.0 | 29.3 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
1.0 | 1.0 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
1.0 | 6.3 | GO:0048291 | isotype switching to IgG isotypes(GO:0048291) |
1.0 | 3.1 | GO:0015840 | urea transport(GO:0015840) urea transmembrane transport(GO:0071918) |
1.0 | 3.1 | GO:0045955 | negative regulation of calcium ion-dependent exocytosis(GO:0045955) |
1.0 | 2.1 | GO:0042532 | negative regulation of tyrosine phosphorylation of STAT protein(GO:0042532) |
1.0 | 3.1 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
1.0 | 3.1 | GO:0061620 | glycolytic process through glucose-6-phosphate(GO:0061620) |
1.0 | 1.0 | GO:0060139 | induction of programmed cell death(GO:0012502) positive regulation of apoptotic process in other organism(GO:0044533) positive regulation by symbiont of host programmed cell death(GO:0052042) positive regulation by symbiont of host apoptotic process(GO:0052151) positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052330) positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052501) positive regulation of apoptotic process by virus(GO:0060139) apoptotic process involved in embryonic digit morphogenesis(GO:1902263) |
1.0 | 6.2 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
1.0 | 7.2 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
1.0 | 4.1 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
1.0 | 3.1 | GO:0070633 | transepithelial transport(GO:0070633) |
1.0 | 4.1 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
1.0 | 4.1 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
1.0 | 1.0 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
1.0 | 1.0 | GO:0032808 | lacrimal gland development(GO:0032808) |
1.0 | 5.1 | GO:0008063 | Toll signaling pathway(GO:0008063) |
1.0 | 3.0 | GO:0044068 | modulation by symbiont of host cellular process(GO:0044068) |
1.0 | 12.2 | GO:0071800 | podosome assembly(GO:0071800) |
1.0 | 16.2 | GO:0048305 | immunoglobulin secretion(GO:0048305) |
1.0 | 4.0 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
1.0 | 3.0 | GO:0030279 | negative regulation of ossification(GO:0030279) |
1.0 | 3.0 | GO:0023019 | signal transduction involved in regulation of gene expression(GO:0023019) |
1.0 | 5.0 | GO:1901017 | negative regulation of potassium ion transmembrane transporter activity(GO:1901017) |
1.0 | 5.0 | GO:0044154 | histone H3-K14 acetylation(GO:0044154) |
1.0 | 2.0 | GO:0033623 | regulation of integrin activation(GO:0033623) |
1.0 | 6.0 | GO:0032620 | interleukin-17 production(GO:0032620) |
1.0 | 1.0 | GO:0048597 | post-embryonic camera-type eye morphogenesis(GO:0048597) |
1.0 | 3.9 | GO:0060283 | negative regulation of oocyte development(GO:0060283) |
1.0 | 1.0 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
1.0 | 10.8 | GO:0000479 | endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000479) |
1.0 | 2.0 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
1.0 | 2.0 | GO:0001757 | somite specification(GO:0001757) |
1.0 | 4.9 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
1.0 | 2.0 | GO:1904528 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
1.0 | 3.9 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
1.0 | 2.0 | GO:1902267 | polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) |
1.0 | 2.0 | GO:0071895 | odontoblast differentiation(GO:0071895) |
1.0 | 4.9 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
1.0 | 1.0 | GO:0010840 | regulation of circadian sleep/wake cycle, wakefulness(GO:0010840) positive regulation of circadian sleep/wake cycle, wakefulness(GO:0010841) circadian sleep/wake cycle, wakefulness(GO:0042746) |
1.0 | 2.9 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
1.0 | 1.9 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
1.0 | 3.8 | GO:0000237 | leptotene(GO:0000237) |
1.0 | 2.9 | GO:0048143 | astrocyte activation(GO:0048143) |
1.0 | 3.8 | GO:0034435 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
1.0 | 1.0 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
1.0 | 3.8 | GO:0032367 | intracellular cholesterol transport(GO:0032367) |
1.0 | 1.0 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
1.0 | 5.7 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.9 | 2.8 | GO:0051639 | actin filament network formation(GO:0051639) |
0.9 | 2.8 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.9 | 2.8 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
0.9 | 3.8 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.9 | 13.1 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.9 | 2.8 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.9 | 0.9 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.9 | 2.8 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.9 | 4.6 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.9 | 6.5 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.9 | 7.4 | GO:1990845 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
0.9 | 1.9 | GO:0071033 | nuclear retention of pre-mRNA at the site of transcription(GO:0071033) |
0.9 | 1.9 | GO:0097503 | sialylation(GO:0097503) |
0.9 | 9.2 | GO:0043276 | anoikis(GO:0043276) |
0.9 | 1.8 | GO:0060717 | chorion development(GO:0060717) extraembryonic membrane development(GO:1903867) |
0.9 | 2.8 | GO:0060789 | hair follicle placode formation(GO:0060789) |
0.9 | 7.4 | GO:0060211 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
0.9 | 5.5 | GO:0001780 | neutrophil homeostasis(GO:0001780) |
0.9 | 6.4 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.9 | 0.9 | GO:0055118 | negative regulation of cardiac muscle contraction(GO:0055118) |
0.9 | 11.0 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.9 | 0.9 | GO:0071332 | cellular response to fructose stimulus(GO:0071332) |
0.9 | 2.7 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.9 | 2.7 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.9 | 3.6 | GO:0061050 | regulation of cell growth involved in cardiac muscle cell development(GO:0061050) |
0.9 | 2.7 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.9 | 0.9 | GO:0032966 | negative regulation of collagen metabolic process(GO:0010713) negative regulation of collagen biosynthetic process(GO:0032966) |
0.9 | 5.4 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.9 | 5.4 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.9 | 5.4 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.9 | 12.5 | GO:0036075 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.9 | 3.6 | GO:1901096 | regulation of autophagosome maturation(GO:1901096) |
0.9 | 7.1 | GO:0051014 | actin filament severing(GO:0051014) |
0.9 | 4.5 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.9 | 5.3 | GO:2000484 | positive regulation of interleukin-8 secretion(GO:2000484) |
0.9 | 3.5 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
0.9 | 0.9 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.9 | 1.8 | GO:0002826 | negative regulation of T-helper 1 type immune response(GO:0002826) |
0.9 | 4.4 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.9 | 4.4 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.9 | 3.5 | GO:0001842 | neural fold formation(GO:0001842) |
0.9 | 2.6 | GO:0002934 | desmosome organization(GO:0002934) |
0.9 | 2.6 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
0.9 | 4.4 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.9 | 0.9 | GO:0014029 | neural crest formation(GO:0014029) |
0.9 | 1.7 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.9 | 0.9 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.9 | 0.9 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.9 | 2.6 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.9 | 2.6 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.9 | 0.9 | GO:0002606 | positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
0.9 | 2.6 | GO:0036394 | amylase secretion(GO:0036394) |
0.9 | 2.6 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
0.9 | 18.9 | GO:0050891 | multicellular organismal water homeostasis(GO:0050891) |
0.9 | 2.6 | GO:0043551 | regulation of phosphatidylinositol 3-kinase activity(GO:0043551) |
0.9 | 21.4 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.9 | 0.9 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.9 | 0.9 | GO:0033087 | negative regulation of immature T cell proliferation(GO:0033087) |
0.9 | 2.6 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.9 | 2.6 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.9 | 3.4 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.9 | 3.4 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
0.9 | 59.6 | GO:0035023 | regulation of Rho protein signal transduction(GO:0035023) |
0.8 | 3.4 | GO:0001927 | exocyst assembly(GO:0001927) |
0.8 | 0.8 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
0.8 | 1.7 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.8 | 1.7 | GO:0045852 | pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
0.8 | 0.8 | GO:2000860 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.8 | 2.5 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.8 | 0.8 | GO:0043369 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment(GO:0043369) |
0.8 | 0.8 | GO:0015744 | succinate transport(GO:0015744) |
0.8 | 0.8 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
0.8 | 4.2 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.8 | 2.5 | GO:0030903 | notochord development(GO:0030903) |
0.8 | 10.1 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.8 | 0.8 | GO:0061010 | gall bladder development(GO:0061010) |
0.8 | 1.7 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
0.8 | 5.0 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.8 | 0.8 | GO:0070235 | regulation of activation-induced cell death of T cells(GO:0070235) negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.8 | 1.7 | GO:0035880 | embryonic nail plate morphogenesis(GO:0035880) |
0.8 | 3.3 | GO:0036336 | dendritic cell migration(GO:0036336) |
0.8 | 3.3 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.8 | 14.9 | GO:0003382 | epithelial cell morphogenesis(GO:0003382) |
0.8 | 4.1 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.8 | 3.3 | GO:0048539 | bone marrow development(GO:0048539) |
0.8 | 2.5 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.8 | 1.6 | GO:0060713 | labyrinthine layer morphogenesis(GO:0060713) |
0.8 | 5.7 | GO:0044794 | positive regulation by host of viral process(GO:0044794) |
0.8 | 1.6 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.8 | 4.1 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
0.8 | 11.4 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
0.8 | 4.0 | GO:0000459 | exonucleolytic trimming involved in rRNA processing(GO:0000459) exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000467) |
0.8 | 0.8 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
0.8 | 0.8 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
0.8 | 1.6 | GO:0032621 | interleukin-18 production(GO:0032621) |
0.8 | 14.3 | GO:0048286 | lung alveolus development(GO:0048286) |
0.8 | 3.2 | GO:0019695 | choline metabolic process(GO:0019695) |
0.8 | 3.2 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.8 | 3.2 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.8 | 0.8 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.8 | 7.1 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.8 | 1.6 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.8 | 1.6 | GO:0015919 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
0.8 | 11.9 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.8 | 4.0 | GO:0043312 | neutrophil degranulation(GO:0043312) |
0.8 | 8.7 | GO:0033198 | response to ATP(GO:0033198) |
0.8 | 0.8 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.8 | 1.6 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.8 | 9.4 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.8 | 2.3 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.8 | 0.8 | GO:0060831 | smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:0060831) |
0.8 | 1.6 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.8 | 3.1 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.8 | 0.8 | GO:2000015 | regulation of determination of dorsal identity(GO:2000015) |
0.8 | 2.3 | GO:0061614 | pri-miRNA transcription from RNA polymerase II promoter(GO:0061614) |
0.8 | 2.3 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
0.8 | 2.3 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.8 | 1.5 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.8 | 3.8 | GO:0031076 | embryonic camera-type eye development(GO:0031076) |
0.8 | 3.8 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
0.8 | 5.3 | GO:0032328 | alanine transport(GO:0032328) |
0.8 | 6.9 | GO:0034368 | macromolecular complex remodeling(GO:0034367) protein-lipid complex remodeling(GO:0034368) plasma lipoprotein particle remodeling(GO:0034369) |
0.8 | 0.8 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.8 | 1.5 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.8 | 2.3 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.8 | 2.3 | GO:2000401 | regulation of lymphocyte migration(GO:2000401) |
0.8 | 0.8 | GO:0048339 | paraxial mesoderm development(GO:0048339) |
0.8 | 2.3 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.8 | 3.8 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.8 | 2.3 | GO:0046133 | pyrimidine ribonucleoside catabolic process(GO:0046133) |
0.8 | 0.8 | GO:0072087 | renal vesicle development(GO:0072087) |
0.8 | 1.5 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
0.8 | 2.3 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.8 | 2.3 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
0.7 | 2.2 | GO:0019355 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.7 | 3.0 | GO:0000469 | cleavage involved in rRNA processing(GO:0000469) |
0.7 | 8.2 | GO:0006706 | steroid catabolic process(GO:0006706) |
0.7 | 2.2 | GO:2000105 | positive regulation of DNA-dependent DNA replication(GO:2000105) |
0.7 | 5.2 | GO:1990118 | sodium ion import(GO:0097369) sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.7 | 0.7 | GO:2000855 | mineralocorticoid secretion(GO:0035931) aldosterone secretion(GO:0035932) regulation of mineralocorticoid secretion(GO:2000855) regulation of aldosterone secretion(GO:2000858) |
0.7 | 2.2 | GO:0051971 | positive regulation of transmission of nerve impulse(GO:0051971) |
0.7 | 0.7 | GO:0071280 | cellular response to copper ion(GO:0071280) |
0.7 | 3.0 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.7 | 4.4 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.7 | 2.2 | GO:0060766 | negative regulation of androgen receptor signaling pathway(GO:0060766) |
0.7 | 5.2 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
0.7 | 2.9 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
0.7 | 2.9 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.7 | 1.5 | GO:0042637 | catagen(GO:0042637) |
0.7 | 2.9 | GO:0033033 | negative regulation of myeloid cell apoptotic process(GO:0033033) |
0.7 | 2.9 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
0.7 | 3.6 | GO:0009202 | deoxyribonucleoside triphosphate biosynthetic process(GO:0009202) |
0.7 | 0.7 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.7 | 0.7 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
0.7 | 1.4 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) |
0.7 | 1.4 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.7 | 4.3 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.7 | 2.2 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.7 | 6.5 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.7 | 1.4 | GO:0045950 | negative regulation of mitotic recombination(GO:0045950) |
0.7 | 1.4 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.7 | 0.7 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.7 | 0.7 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.7 | 2.9 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.7 | 7.2 | GO:0002040 | sprouting angiogenesis(GO:0002040) |
0.7 | 7.9 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.7 | 0.7 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
0.7 | 1.4 | GO:1902172 | keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
0.7 | 2.1 | GO:0060056 | mammary gland involution(GO:0060056) |
0.7 | 3.5 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.7 | 0.7 | GO:1903984 | positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.7 | 0.7 | GO:0048048 | embryonic eye morphogenesis(GO:0048048) |
0.7 | 0.7 | GO:0014832 | urinary bladder smooth muscle contraction(GO:0014832) |
0.7 | 4.2 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.7 | 1.4 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.7 | 0.7 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.7 | 14.7 | GO:0006940 | regulation of smooth muscle contraction(GO:0006940) |
0.7 | 0.7 | GO:0070875 | positive regulation of glycogen metabolic process(GO:0070875) |
0.7 | 1.4 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.7 | 0.7 | GO:0014055 | acetylcholine secretion, neurotransmission(GO:0014055) regulation of acetylcholine secretion, neurotransmission(GO:0014056) |
0.7 | 1.4 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.7 | 9.7 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.7 | 4.8 | GO:0010470 | regulation of gastrulation(GO:0010470) |
0.7 | 2.1 | GO:0045836 | positive regulation of meiotic nuclear division(GO:0045836) |
0.7 | 1.4 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.7 | 4.1 | GO:0010669 | epithelial structure maintenance(GO:0010669) |
0.7 | 3.4 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.7 | 0.7 | GO:0010715 | regulation of extracellular matrix disassembly(GO:0010715) |
0.7 | 1.4 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.7 | 2.7 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.7 | 3.4 | GO:0035066 | positive regulation of histone acetylation(GO:0035066) |
0.7 | 1.4 | GO:0048261 | negative regulation of receptor-mediated endocytosis(GO:0048261) |
0.7 | 1.4 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.7 | 2.0 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.7 | 1.3 | GO:0002930 | trabecular meshwork development(GO:0002930) |
0.7 | 1.3 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.7 | 2.0 | GO:0046125 | thymidine metabolic process(GO:0046104) pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.7 | 4.0 | GO:0030318 | melanocyte differentiation(GO:0030318) |
0.7 | 0.7 | GO:0090114 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) COPII-coated vesicle budding(GO:0090114) |
0.7 | 3.3 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.7 | 2.7 | GO:0019478 | D-amino acid catabolic process(GO:0019478) |
0.7 | 2.0 | GO:0033216 | ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) |
0.7 | 4.0 | GO:0046579 | positive regulation of Ras protein signal transduction(GO:0046579) |
0.7 | 2.6 | GO:0055022 | negative regulation of cardiac muscle tissue growth(GO:0055022) negative regulation of heart growth(GO:0061117) |
0.7 | 4.6 | GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
0.7 | 1.3 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.7 | 3.9 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
0.7 | 1.3 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.7 | 2.0 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.6 | 0.6 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.6 | 2.6 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.6 | 2.6 | GO:0010667 | negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
0.6 | 1.9 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.6 | 3.9 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
0.6 | 12.9 | GO:0048678 | response to axon injury(GO:0048678) |
0.6 | 0.6 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
0.6 | 0.6 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
0.6 | 3.2 | GO:0045922 | negative regulation of fatty acid metabolic process(GO:0045922) |
0.6 | 8.3 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.6 | 1.3 | GO:0045091 | regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) |
0.6 | 0.6 | GO:0043129 | surfactant homeostasis(GO:0043129) |
0.6 | 0.6 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.6 | 1.9 | GO:0007296 | vitellogenesis(GO:0007296) |
0.6 | 3.2 | GO:0070842 | aggresome assembly(GO:0070842) |
0.6 | 0.6 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
0.6 | 10.8 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
0.6 | 3.2 | GO:0009128 | purine nucleoside monophosphate catabolic process(GO:0009128) |
0.6 | 8.9 | GO:0060325 | face morphogenesis(GO:0060325) |
0.6 | 1.3 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.6 | 1.3 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) |
0.6 | 1.9 | GO:0097012 | response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
0.6 | 5.0 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.6 | 1.3 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.6 | 1.3 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.6 | 18.3 | GO:0007229 | integrin-mediated signaling pathway(GO:0007229) |
0.6 | 1.9 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
0.6 | 0.6 | GO:0000019 | regulation of mitotic recombination(GO:0000019) |
0.6 | 0.6 | GO:0097527 | necroptotic signaling pathway(GO:0097527) |
0.6 | 0.6 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.6 | 1.2 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.6 | 7.5 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.6 | 7.4 | GO:0043248 | proteasome assembly(GO:0043248) |
0.6 | 1.9 | GO:1902993 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
0.6 | 0.6 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.6 | 2.4 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.6 | 1.8 | GO:0002021 | response to dietary excess(GO:0002021) |
0.6 | 14.0 | GO:0050775 | positive regulation of dendrite morphogenesis(GO:0050775) |
0.6 | 0.6 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
0.6 | 1.8 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.6 | 3.6 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.6 | 1.8 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
0.6 | 1.8 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.6 | 2.4 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.6 | 1.2 | GO:0045410 | positive regulation of interleukin-6 biosynthetic process(GO:0045410) |
0.6 | 3.6 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
0.6 | 1.8 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.6 | 10.8 | GO:0048247 | lymphocyte chemotaxis(GO:0048247) |
0.6 | 1.2 | GO:0016264 | gap junction assembly(GO:0016264) |
0.6 | 1.2 | GO:0072553 | terminal button organization(GO:0072553) |
0.6 | 0.6 | GO:2000553 | positive regulation of T-helper 2 cell cytokine production(GO:2000553) |
0.6 | 1.2 | GO:0031958 | corticosteroid receptor signaling pathway(GO:0031958) |
0.6 | 3.0 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.6 | 1.8 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.6 | 1.2 | GO:0046005 | positive regulation of circadian sleep/wake cycle, REM sleep(GO:0046005) |
0.6 | 1.8 | GO:0000492 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.6 | 2.4 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.6 | 4.1 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.6 | 4.1 | GO:0002251 | organ or tissue specific immune response(GO:0002251) mucosal immune response(GO:0002385) |
0.6 | 2.4 | GO:0043586 | tongue development(GO:0043586) |
0.6 | 2.4 | GO:0045075 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.6 | 1.8 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.6 | 15.2 | GO:0002062 | chondrocyte differentiation(GO:0002062) |
0.6 | 1.7 | GO:0019249 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.6 | 4.1 | GO:0002467 | germinal center formation(GO:0002467) |
0.6 | 3.5 | GO:0045060 | negative thymic T cell selection(GO:0045060) |
0.6 | 6.3 | GO:0048011 | neurotrophin TRK receptor signaling pathway(GO:0048011) |
0.6 | 1.1 | GO:0002540 | leukotriene production involved in inflammatory response(GO:0002540) |
0.6 | 6.3 | GO:0045879 | negative regulation of smoothened signaling pathway(GO:0045879) |
0.6 | 1.1 | GO:0046929 | negative regulation of neurotransmitter secretion(GO:0046929) |
0.6 | 4.6 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
0.6 | 2.3 | GO:0045408 | regulation of interleukin-6 biosynthetic process(GO:0045408) |
0.6 | 9.7 | GO:0010107 | potassium ion import(GO:0010107) |
0.6 | 1.7 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
0.6 | 11.4 | GO:0070373 | negative regulation of ERK1 and ERK2 cascade(GO:0070373) |
0.6 | 0.6 | GO:0045625 | regulation of T-helper 1 cell differentiation(GO:0045625) |
0.6 | 0.6 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.6 | 0.6 | GO:0033690 | positive regulation of osteoblast proliferation(GO:0033690) |
0.6 | 6.8 | GO:0043046 | DNA methylation involved in gamete generation(GO:0043046) |
0.6 | 0.6 | GO:1904996 | positive regulation of leukocyte tethering or rolling(GO:1903238) positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
0.6 | 0.6 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
0.6 | 10.7 | GO:0071559 | response to transforming growth factor beta(GO:0071559) |
0.6 | 0.6 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.6 | 23.0 | GO:0014020 | primary neural tube formation(GO:0014020) |
0.6 | 0.6 | GO:0090045 | positive regulation of deacetylase activity(GO:0090045) |
0.6 | 1.1 | GO:0030910 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.6 | 3.3 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.6 | 2.8 | GO:2000778 | positive regulation of interleukin-6 secretion(GO:2000778) |
0.6 | 0.6 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
0.6 | 3.3 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
0.6 | 10.5 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.6 | 1.7 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.5 | 2.2 | GO:0080009 | mRNA methylation(GO:0080009) |
0.5 | 1.6 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.5 | 1.1 | GO:0060027 | convergent extension involved in gastrulation(GO:0060027) |
0.5 | 10.4 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.5 | 1.6 | GO:0015802 | basic amino acid transport(GO:0015802) |
0.5 | 7.1 | GO:1901016 | regulation of potassium ion transmembrane transporter activity(GO:1901016) |
0.5 | 4.4 | GO:1902230 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
0.5 | 1.6 | GO:0006108 | malate metabolic process(GO:0006108) |
0.5 | 16.8 | GO:0050821 | protein stabilization(GO:0050821) |
0.5 | 3.3 | GO:0046621 | negative regulation of organ growth(GO:0046621) |
0.5 | 6.0 | GO:0009303 | rRNA transcription(GO:0009303) |
0.5 | 2.2 | GO:0060177 | regulation of angiotensin metabolic process(GO:0060177) |
0.5 | 2.7 | GO:0048484 | enteric nervous system development(GO:0048484) |
0.5 | 1.1 | GO:0045297 | mating plug formation(GO:0042628) post-mating behavior(GO:0045297) |
0.5 | 0.5 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.5 | 1.6 | GO:0009438 | methylglyoxal metabolic process(GO:0009438) methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.5 | 4.8 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.5 | 7.5 | GO:0014068 | positive regulation of phosphatidylinositol 3-kinase signaling(GO:0014068) |
0.5 | 1.6 | GO:1901985 | positive regulation of protein acetylation(GO:1901985) |
0.5 | 0.5 | GO:0033092 | positive regulation of immature T cell proliferation in thymus(GO:0033092) |
0.5 | 1.6 | GO:0010155 | regulation of proton transport(GO:0010155) |
0.5 | 1.1 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
0.5 | 2.1 | GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) |
0.5 | 0.5 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.5 | 1.1 | GO:0014072 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.5 | 1.6 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.5 | 0.5 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.5 | 0.5 | GO:0010454 | negative regulation of cell fate commitment(GO:0010454) |
0.5 | 0.5 | GO:0033206 | meiotic cytokinesis(GO:0033206) |
0.5 | 4.2 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.5 | 1.1 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.5 | 1.0 | GO:1904888 | cranial skeletal system development(GO:1904888) |
0.5 | 1.6 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.5 | 9.9 | GO:0045668 | negative regulation of osteoblast differentiation(GO:0045668) |
0.5 | 1.0 | GO:0001787 | natural killer cell proliferation(GO:0001787) |
0.5 | 1.6 | GO:0048478 | replication fork protection(GO:0048478) |
0.5 | 13.5 | GO:0007569 | cell aging(GO:0007569) |
0.5 | 0.5 | GO:0034627 | 'de novo' NAD biosynthetic process(GO:0034627) |
0.5 | 1.6 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.5 | 2.1 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.5 | 1.5 | GO:0090190 | positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
0.5 | 6.7 | GO:0042573 | retinoic acid metabolic process(GO:0042573) |
0.5 | 1.0 | GO:0060338 | regulation of type I interferon-mediated signaling pathway(GO:0060338) |
0.5 | 1.0 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.5 | 0.5 | GO:0043045 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.5 | 1.0 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.5 | 0.5 | GO:0071043 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.5 | 3.6 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.5 | 0.5 | GO:0090031 | positive regulation of steroid hormone biosynthetic process(GO:0090031) |
0.5 | 2.0 | GO:0010332 | response to gamma radiation(GO:0010332) |
0.5 | 0.5 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.5 | 0.5 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.5 | 0.5 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.5 | 5.6 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.5 | 1.0 | GO:0032264 | IMP salvage(GO:0032264) |
0.5 | 1.5 | GO:0045990 | carbon catabolite regulation of transcription(GO:0045990) |
0.5 | 1.5 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.5 | 1.5 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.5 | 0.5 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.5 | 2.0 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.5 | 2.0 | GO:0035977 | protein deglycosylation involved in glycoprotein catabolic process(GO:0035977) protein demannosylation(GO:0036507) protein alpha-1,2-demannosylation(GO:0036508) mannose trimming involved in glycoprotein ERAD pathway(GO:1904382) |
0.5 | 1.5 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.5 | 15.4 | GO:0007566 | embryo implantation(GO:0007566) |
0.5 | 1.5 | GO:0032789 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.5 | 2.0 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.5 | 4.9 | GO:0031295 | T cell costimulation(GO:0031295) |
0.5 | 1.5 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.5 | 1.5 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.5 | 0.5 | GO:0034204 | lipid translocation(GO:0034204) |
0.5 | 0.5 | GO:0033687 | osteoblast proliferation(GO:0033687) |
0.5 | 0.5 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.5 | 0.5 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
0.5 | 1.4 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.5 | 3.4 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.5 | 0.5 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.5 | 3.4 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.5 | 2.4 | GO:0030033 | microvillus assembly(GO:0030033) |
0.5 | 10.5 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
0.5 | 21.0 | GO:0035914 | skeletal muscle cell differentiation(GO:0035914) |
0.5 | 0.5 | GO:0060613 | fat pad development(GO:0060613) |
0.5 | 1.9 | GO:0070873 | regulation of glycogen metabolic process(GO:0070873) |
0.5 | 2.8 | GO:0032757 | positive regulation of interleukin-8 production(GO:0032757) |
0.5 | 5.7 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.5 | 7.0 | GO:1901571 | icosanoid transport(GO:0071715) fatty acid derivative transport(GO:1901571) |
0.5 | 1.4 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.5 | 1.4 | GO:0061084 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) negative regulation of protein folding(GO:1903333) |
0.5 | 0.9 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.5 | 1.4 | GO:0036230 | granulocyte activation(GO:0036230) |
0.5 | 1.4 | GO:1902510 | regulation of apoptotic DNA fragmentation(GO:1902510) regulation of DNA catabolic process(GO:1903624) |
0.5 | 0.9 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.5 | 0.9 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.5 | 0.5 | GO:1902591 | single-organism membrane budding(GO:1902591) |
0.5 | 2.3 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.5 | 0.5 | GO:2000152 | regulation of ubiquitin-specific protease activity(GO:2000152) |
0.5 | 4.1 | GO:0006312 | mitotic recombination(GO:0006312) |
0.5 | 0.5 | GO:0001834 | trophectodermal cell proliferation(GO:0001834) |
0.5 | 3.6 | GO:0042711 | maternal behavior(GO:0042711) |
0.5 | 3.6 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.5 | 2.7 | GO:0001771 | immunological synapse formation(GO:0001771) |
0.5 | 0.5 | GO:0032077 | positive regulation of deoxyribonuclease activity(GO:0032077) |
0.5 | 2.7 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.5 | 2.3 | GO:0070234 | positive regulation of T cell apoptotic process(GO:0070234) |
0.5 | 1.8 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.5 | 1.4 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.5 | 0.5 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.5 | 1.4 | GO:0010165 | response to X-ray(GO:0010165) |
0.4 | 3.6 | GO:0032402 | melanosome transport(GO:0032402) |
0.4 | 1.8 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.4 | 1.8 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.4 | 0.4 | GO:0032650 | regulation of interleukin-1 alpha production(GO:0032650) |
0.4 | 0.4 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) |
0.4 | 0.9 | GO:0015755 | fructose transport(GO:0015755) |
0.4 | 0.4 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
0.4 | 2.6 | GO:0034142 | toll-like receptor 4 signaling pathway(GO:0034142) |
0.4 | 0.4 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.4 | 1.7 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.4 | 6.1 | GO:0003281 | ventricular septum development(GO:0003281) |
0.4 | 1.3 | GO:0040034 | regulation of development, heterochronic(GO:0040034) |
0.4 | 11.3 | GO:0031424 | keratinization(GO:0031424) |
0.4 | 4.3 | GO:0032835 | glomerulus development(GO:0032835) |
0.4 | 2.2 | GO:0036035 | osteoclast development(GO:0036035) |
0.4 | 1.3 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) |
0.4 | 1.3 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.4 | 8.1 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.4 | 1.3 | GO:0033015 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) |
0.4 | 1.3 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.4 | 1.3 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.4 | 2.9 | GO:0009948 | anterior/posterior axis specification(GO:0009948) |
0.4 | 0.4 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.4 | 6.3 | GO:0030574 | collagen catabolic process(GO:0030574) multicellular organism catabolic process(GO:0044243) |
0.4 | 0.4 | GO:0032768 | regulation of monooxygenase activity(GO:0032768) |
0.4 | 4.6 | GO:0097186 | amelogenesis(GO:0097186) |
0.4 | 1.3 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.4 | 2.1 | GO:0097484 | dendrite extension(GO:0097484) |
0.4 | 1.7 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.4 | 0.4 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
0.4 | 1.7 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
0.4 | 1.2 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.4 | 4.5 | GO:0030514 | negative regulation of BMP signaling pathway(GO:0030514) |
0.4 | 1.6 | GO:0060433 | bronchus development(GO:0060433) lobar bronchus epithelium development(GO:0060481) |
0.4 | 0.8 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.4 | 0.8 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.4 | 4.9 | GO:0048747 | muscle fiber development(GO:0048747) |
0.4 | 2.4 | GO:0019731 | antibacterial humoral response(GO:0019731) |
0.4 | 2.8 | GO:0032964 | collagen biosynthetic process(GO:0032964) |
0.4 | 2.0 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.4 | 5.2 | GO:0050810 | regulation of steroid biosynthetic process(GO:0050810) |
0.4 | 1.2 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.4 | 1.6 | GO:0090103 | cochlea morphogenesis(GO:0090103) |
0.4 | 0.4 | GO:0031657 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031657) |
0.4 | 5.2 | GO:0010633 | negative regulation of epithelial cell migration(GO:0010633) |
0.4 | 0.4 | GO:0071500 | cellular response to nitrosative stress(GO:0071500) |
0.4 | 4.4 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.4 | 0.4 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.4 | 2.8 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) |
0.4 | 1.2 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
0.4 | 0.8 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.4 | 2.4 | GO:0010640 | regulation of platelet-derived growth factor receptor signaling pathway(GO:0010640) |
0.4 | 1.6 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.4 | 14.5 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.4 | 0.4 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
0.4 | 1.2 | GO:0051917 | regulation of fibrinolysis(GO:0051917) positive regulation of fibrinolysis(GO:0051919) |
0.4 | 0.8 | GO:0042851 | L-alanine metabolic process(GO:0042851) |
0.4 | 0.8 | GO:0061743 | motor learning(GO:0061743) |
0.4 | 0.4 | GO:0003162 | atrioventricular node development(GO:0003162) |
0.4 | 1.2 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.4 | 1.9 | GO:0048701 | embryonic cranial skeleton morphogenesis(GO:0048701) |
0.4 | 5.0 | GO:0006491 | N-glycan processing(GO:0006491) |
0.4 | 1.5 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.4 | 1.9 | GO:0001502 | cartilage condensation(GO:0001502) cell aggregation(GO:0098743) |
0.4 | 0.4 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
0.4 | 1.1 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.4 | 3.0 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.4 | 0.4 | GO:0035989 | tendon development(GO:0035989) |
0.4 | 7.2 | GO:2001022 | positive regulation of response to DNA damage stimulus(GO:2001022) |
0.4 | 0.8 | GO:0007000 | nucleolus organization(GO:0007000) |
0.4 | 1.5 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.4 | 3.0 | GO:0060046 | regulation of acrosome reaction(GO:0060046) |
0.4 | 1.5 | GO:0055024 | regulation of cardiac muscle tissue development(GO:0055024) |
0.4 | 1.1 | GO:0032735 | positive regulation of interleukin-12 production(GO:0032735) |
0.4 | 0.4 | GO:0033504 | floor plate development(GO:0033504) |
0.4 | 1.1 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.4 | 0.7 | GO:0031049 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.4 | 2.6 | GO:0030513 | positive regulation of BMP signaling pathway(GO:0030513) |
0.4 | 1.1 | GO:0070986 | left/right axis specification(GO:0070986) |
0.4 | 1.1 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.4 | 0.7 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.4 | 0.7 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.4 | 0.7 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.4 | 0.7 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
0.4 | 0.4 | GO:0010993 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
0.4 | 2.2 | GO:0015816 | glycine transport(GO:0015816) |
0.4 | 2.2 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.4 | 0.4 | GO:0070570 | regulation of neuron projection regeneration(GO:0070570) |
0.4 | 1.1 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.4 | 2.2 | GO:0031441 | negative regulation of mRNA 3'-end processing(GO:0031441) |
0.4 | 0.4 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.4 | 1.1 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.4 | 0.4 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
0.4 | 1.5 | GO:0036089 | cleavage furrow formation(GO:0036089) |
0.4 | 1.5 | GO:0031100 | organ regeneration(GO:0031100) |
0.4 | 0.4 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.4 | 8.3 | GO:0030282 | bone mineralization(GO:0030282) |
0.4 | 4.3 | GO:0061462 | protein localization to lysosome(GO:0061462) |
0.4 | 0.7 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
0.4 | 0.4 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.4 | 2.5 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.4 | 4.3 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.4 | 0.4 | GO:0009217 | dGTP catabolic process(GO:0006203) purine deoxyribonucleoside triphosphate catabolic process(GO:0009217) |
0.4 | 0.7 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.4 | 5.3 | GO:0044380 | protein localization to cytoskeleton(GO:0044380) |
0.4 | 0.7 | GO:0006562 | proline catabolic process(GO:0006562) |
0.4 | 1.1 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
0.4 | 0.4 | GO:0002638 | negative regulation of immunoglobulin production(GO:0002638) |
0.4 | 0.7 | GO:0046499 | S-adenosylmethioninamine metabolic process(GO:0046499) |
0.4 | 2.1 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.4 | 0.4 | GO:0007529 | establishment of synaptic specificity at neuromuscular junction(GO:0007529) |
0.4 | 1.1 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.4 | 1.4 | GO:2001198 | regulation of dendritic cell differentiation(GO:2001198) negative regulation of dendritic cell differentiation(GO:2001199) |
0.4 | 1.4 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.3 | 0.3 | GO:1902285 | semaphorin-plexin signaling pathway involved in neuron projection guidance(GO:1902285) |
0.3 | 0.3 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
0.3 | 0.3 | GO:0003170 | heart valve development(GO:0003170) |
0.3 | 1.4 | GO:0045910 | negative regulation of DNA recombination(GO:0045910) |
0.3 | 3.5 | GO:0006734 | NADH metabolic process(GO:0006734) |
0.3 | 1.0 | GO:0002446 | neutrophil mediated immunity(GO:0002446) |
0.3 | 1.4 | GO:0007144 | female meiosis I(GO:0007144) |
0.3 | 0.7 | GO:1900106 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.3 | 0.3 | GO:0071436 | sodium ion export(GO:0071436) |
0.3 | 0.3 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
0.3 | 0.3 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.3 | 0.3 | GO:0060019 | radial glial cell differentiation(GO:0060019) |
0.3 | 1.0 | GO:0018158 | protein oxidation(GO:0018158) |
0.3 | 2.7 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.3 | 1.4 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.3 | 0.3 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.3 | 1.0 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.3 | 0.3 | GO:0019042 | viral latency(GO:0019042) |
0.3 | 1.3 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.3 | 0.7 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.3 | 2.0 | GO:0002507 | tolerance induction(GO:0002507) |
0.3 | 0.3 | GO:0060033 | anatomical structure regression(GO:0060033) |
0.3 | 0.7 | GO:0009624 | response to nematode(GO:0009624) |
0.3 | 1.0 | GO:0034505 | tooth mineralization(GO:0034505) |
0.3 | 1.0 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.3 | 1.0 | GO:0016559 | peroxisome fission(GO:0016559) |
0.3 | 0.3 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.3 | 0.7 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.3 | 3.6 | GO:2001244 | positive regulation of intrinsic apoptotic signaling pathway(GO:2001244) |
0.3 | 0.6 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.3 | 3.9 | GO:0043489 | RNA stabilization(GO:0043489) |
0.3 | 1.0 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.3 | 1.3 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.3 | 0.3 | GO:2000121 | regulation of removal of superoxide radicals(GO:2000121) |
0.3 | 1.6 | GO:0006388 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.3 | 0.3 | GO:0022617 | extracellular matrix disassembly(GO:0022617) |
0.3 | 0.3 | GO:0032769 | negative regulation of monooxygenase activity(GO:0032769) |
0.3 | 0.6 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.3 | 0.6 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.3 | 2.5 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.3 | 4.4 | GO:0043631 | mRNA polyadenylation(GO:0006378) RNA polyadenylation(GO:0043631) |
0.3 | 0.9 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.3 | 0.9 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
0.3 | 7.5 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
0.3 | 0.9 | GO:0001779 | natural killer cell differentiation(GO:0001779) |
0.3 | 1.6 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.3 | 0.3 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.3 | 2.8 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.3 | 1.2 | GO:0034080 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.3 | 0.9 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.3 | 0.9 | GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
0.3 | 0.3 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
0.3 | 0.6 | GO:0060023 | soft palate development(GO:0060023) |
0.3 | 2.5 | GO:0060261 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
0.3 | 6.4 | GO:0006284 | base-excision repair(GO:0006284) |
0.3 | 1.8 | GO:0031061 | negative regulation of histone methylation(GO:0031061) |
0.3 | 1.5 | GO:0051608 | histamine transport(GO:0051608) |
0.3 | 2.4 | GO:0035094 | response to nicotine(GO:0035094) |
0.3 | 2.4 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.3 | 1.8 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.3 | 1.8 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.3 | 0.3 | GO:0048070 | regulation of developmental pigmentation(GO:0048070) |
0.3 | 1.2 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.3 | 0.9 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.3 | 1.8 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.3 | 1.5 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.3 | 1.5 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.3 | 1.8 | GO:0032095 | regulation of response to food(GO:0032095) negative regulation of response to food(GO:0032096) |
0.3 | 4.4 | GO:0071353 | cellular response to interleukin-4(GO:0071353) |
0.3 | 0.6 | GO:0043097 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.3 | 0.3 | GO:0051589 | negative regulation of neurotransmitter transport(GO:0051589) |
0.3 | 0.6 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
0.3 | 2.0 | GO:0030851 | granulocyte differentiation(GO:0030851) |
0.3 | 0.9 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.3 | 2.6 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.3 | 1.4 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
0.3 | 0.3 | GO:0060631 | regulation of meiosis I(GO:0060631) |
0.3 | 0.3 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.3 | 0.3 | GO:0071637 | monocyte chemotactic protein-1 production(GO:0071605) regulation of monocyte chemotactic protein-1 production(GO:0071637) |
0.3 | 0.3 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
0.3 | 1.1 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.3 | 0.8 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.3 | 0.6 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.3 | 2.0 | GO:0043949 | regulation of cAMP-mediated signaling(GO:0043949) |
0.3 | 0.8 | GO:0051182 | coenzyme transport(GO:0051182) |
0.3 | 1.7 | GO:0051299 | centrosome separation(GO:0051299) |
0.3 | 4.5 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.3 | 0.6 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.3 | 2.8 | GO:0051443 | positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
0.3 | 0.6 | GO:0002360 | T cell lineage commitment(GO:0002360) |
0.3 | 0.3 | GO:0061738 | late endosomal microautophagy(GO:0061738) |
0.3 | 5.8 | GO:0048864 | stem cell development(GO:0048864) |
0.3 | 0.3 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.3 | 1.4 | GO:0045616 | regulation of keratinocyte differentiation(GO:0045616) |
0.3 | 1.1 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.3 | 0.5 | GO:0060120 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.3 | 4.1 | GO:0030032 | lamellipodium assembly(GO:0030032) |
0.3 | 2.7 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.3 | 3.2 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.3 | 0.5 | GO:0010171 | body morphogenesis(GO:0010171) |
0.3 | 0.5 | GO:0001805 | type III hypersensitivity(GO:0001802) regulation of type III hypersensitivity(GO:0001803) positive regulation of type III hypersensitivity(GO:0001805) |
0.3 | 6.9 | GO:1901998 | toxin transport(GO:1901998) |
0.3 | 0.3 | GO:0033574 | response to testosterone(GO:0033574) |
0.3 | 0.3 | GO:0007262 | STAT protein import into nucleus(GO:0007262) |
0.3 | 0.5 | GO:0051447 | negative regulation of meiotic cell cycle(GO:0051447) |
0.3 | 0.8 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.3 | 1.6 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
0.3 | 0.3 | GO:1900102 | negative regulation of endoplasmic reticulum unfolded protein response(GO:1900102) |
0.3 | 0.5 | GO:2000191 | regulation of fatty acid transport(GO:2000191) |
0.3 | 0.3 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.3 | 2.3 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) negative regulation of mRNA processing(GO:0050686) |
0.3 | 0.5 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.3 | 0.3 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.3 | 0.3 | GO:0030239 | myofibril assembly(GO:0030239) |
0.3 | 0.8 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
0.3 | 4.1 | GO:0048704 | embryonic skeletal system morphogenesis(GO:0048704) |
0.3 | 0.3 | GO:0003230 | cardiac atrium development(GO:0003230) |
0.3 | 0.3 | GO:0040031 | snRNA modification(GO:0040031) |
0.3 | 0.3 | GO:0032071 | regulation of endodeoxyribonuclease activity(GO:0032071) |
0.3 | 1.5 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.2 | 1.0 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.2 | 2.0 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.2 | 0.5 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
0.2 | 1.0 | GO:0000012 | single strand break repair(GO:0000012) |
0.2 | 0.2 | GO:0019048 | modulation by virus of host morphology or physiology(GO:0019048) |
0.2 | 2.4 | GO:0006336 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
0.2 | 0.5 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.2 | 1.2 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.2 | 0.7 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.2 | 0.5 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.2 | 0.7 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.2 | 0.5 | GO:0002370 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.2 | 0.2 | GO:0002572 | pro-T cell differentiation(GO:0002572) |
0.2 | 0.2 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.2 | 0.9 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.2 | 1.4 | GO:0044406 | adhesion of symbiont to host(GO:0044406) |
0.2 | 0.2 | GO:0043320 | natural killer cell degranulation(GO:0043320) |
0.2 | 0.9 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.2 | 0.5 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
0.2 | 0.2 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
0.2 | 0.5 | GO:1901299 | negative regulation of hydrogen peroxide-mediated programmed cell death(GO:1901299) |
0.2 | 0.2 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
0.2 | 0.2 | GO:0006069 | ethanol metabolic process(GO:0006067) ethanol oxidation(GO:0006069) |
0.2 | 4.3 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.2 | 0.2 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.2 | 1.8 | GO:0032755 | positive regulation of interleukin-6 production(GO:0032755) |
0.2 | 0.2 | GO:0001844 | protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
0.2 | 1.1 | GO:0046184 | aldehyde biosynthetic process(GO:0046184) |
0.2 | 2.3 | GO:1905145 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.2 | 0.9 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.2 | 1.3 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.2 | 1.6 | GO:0002566 | somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.2 | 0.2 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.2 | 0.4 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
0.2 | 0.9 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.2 | 0.9 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.2 | 0.4 | GO:1901503 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) cellular lipid biosynthetic process(GO:0097384) ether biosynthetic process(GO:1901503) |
0.2 | 0.7 | GO:0002760 | positive regulation of antimicrobial humoral response(GO:0002760) |
0.2 | 0.4 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.2 | 1.8 | GO:0045638 | negative regulation of myeloid cell differentiation(GO:0045638) |
0.2 | 0.2 | GO:0006705 | mineralocorticoid biosynthetic process(GO:0006705) |
0.2 | 0.4 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.2 | 0.9 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.2 | 0.7 | GO:0042756 | drinking behavior(GO:0042756) |
0.2 | 1.1 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.2 | 0.2 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.2 | 0.2 | GO:0046070 | dGTP metabolic process(GO:0046070) |
0.2 | 0.2 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.2 | 0.4 | GO:0021562 | vestibulocochlear nerve development(GO:0021562) |
0.2 | 0.2 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.2 | 1.3 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
0.2 | 0.2 | GO:2000738 | positive regulation of stem cell differentiation(GO:2000738) |
0.2 | 0.6 | GO:0033136 | serine phosphorylation of STAT3 protein(GO:0033136) |
0.2 | 0.6 | GO:0015888 | thiamine transport(GO:0015888) |
0.2 | 0.4 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
0.2 | 3.6 | GO:0035456 | response to interferon-beta(GO:0035456) |
0.2 | 0.8 | GO:0032233 | positive regulation of actin filament bundle assembly(GO:0032233) |
0.2 | 1.0 | GO:0019985 | translesion synthesis(GO:0019985) |
0.2 | 0.4 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.2 | 0.2 | GO:0002759 | regulation of antimicrobial humoral response(GO:0002759) |
0.2 | 0.6 | GO:0051132 | NK T cell activation(GO:0051132) |
0.2 | 0.2 | GO:0021794 | thalamus development(GO:0021794) |
0.2 | 2.4 | GO:0000281 | mitotic cytokinesis(GO:0000281) |
0.2 | 1.4 | GO:0097499 | protein localization to nonmotile primary cilium(GO:0097499) |
0.2 | 0.4 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.2 | 4.6 | GO:0030509 | BMP signaling pathway(GO:0030509) |
0.2 | 2.4 | GO:0050672 | negative regulation of mononuclear cell proliferation(GO:0032945) negative regulation of lymphocyte proliferation(GO:0050672) |
0.2 | 0.2 | GO:0060767 | epithelial cell proliferation involved in prostate gland development(GO:0060767) regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) |
0.2 | 0.2 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
0.2 | 0.6 | GO:2000780 | negative regulation of DNA repair(GO:0045738) negative regulation of double-strand break repair(GO:2000780) |
0.2 | 0.8 | GO:0034063 | stress granule assembly(GO:0034063) |
0.2 | 0.6 | GO:0045402 | interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.2 | 0.6 | GO:0009249 | protein lipoylation(GO:0009249) |
0.2 | 0.8 | GO:1902188 | positive regulation of viral release from host cell(GO:1902188) |
0.2 | 2.7 | GO:0035082 | axoneme assembly(GO:0035082) |
0.2 | 0.4 | GO:0021554 | optic nerve development(GO:0021554) |
0.2 | 1.9 | GO:0035058 | nonmotile primary cilium assembly(GO:0035058) |
0.2 | 2.5 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.2 | 0.4 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.2 | 1.2 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.2 | 0.2 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.2 | 0.2 | GO:0051057 | positive regulation of small GTPase mediated signal transduction(GO:0051057) |
0.2 | 0.6 | GO:1901533 | negative regulation of hematopoietic progenitor cell differentiation(GO:1901533) |
0.2 | 1.7 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.2 | 1.5 | GO:1901072 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) glucosamine-containing compound catabolic process(GO:1901072) |
0.2 | 0.6 | GO:0006551 | leucine metabolic process(GO:0006551) |
0.2 | 1.9 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.2 | 0.6 | GO:0001878 | response to yeast(GO:0001878) |
0.2 | 0.4 | GO:0060512 | prostate gland morphogenesis(GO:0060512) |
0.2 | 1.1 | GO:0007549 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.2 | 1.1 | GO:0035050 | embryonic heart tube development(GO:0035050) |
0.2 | 0.2 | GO:0052205 | modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modulation by host of symbiont catalytic activity(GO:0052422) modification by host of symbiont molecular function(GO:0052428) |
0.2 | 0.2 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.2 | 0.2 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
0.2 | 0.4 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.2 | 0.2 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
0.2 | 1.3 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.2 | 0.6 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.2 | 1.1 | GO:0042436 | tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) |
0.2 | 0.2 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.2 | 0.2 | GO:0071545 | inositol phosphate catabolic process(GO:0071545) |
0.2 | 0.9 | GO:0071569 | protein ufmylation(GO:0071569) protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.2 | 0.7 | GO:0046653 | tetrahydrofolate metabolic process(GO:0046653) |
0.2 | 0.4 | GO:0032825 | positive regulation of natural killer cell differentiation(GO:0032825) |
0.2 | 0.2 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.2 | 1.1 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.2 | 0.2 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.2 | 0.7 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.2 | 0.5 | GO:0018195 | peptidyl-arginine modification(GO:0018195) |
0.2 | 0.2 | GO:0034214 | protein hexamerization(GO:0034214) |
0.2 | 0.2 | GO:0070920 | regulation of production of small RNA involved in gene silencing by RNA(GO:0070920) |
0.2 | 0.2 | GO:0032495 | response to muramyl dipeptide(GO:0032495) |
0.2 | 1.1 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
0.2 | 1.0 | GO:0051293 | establishment of spindle localization(GO:0051293) |
0.2 | 0.5 | GO:0032098 | regulation of appetite(GO:0032098) |
0.2 | 0.2 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.2 | 0.2 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) |
0.2 | 0.5 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.2 | 1.5 | GO:0048490 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.2 | 0.3 | GO:0006498 | N-terminal protein lipidation(GO:0006498) |
0.2 | 2.4 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.2 | 0.3 | GO:0007398 | ectoderm development(GO:0007398) |
0.2 | 0.3 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.2 | 1.3 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.2 | 0.2 | GO:0060126 | somatotropin secreting cell differentiation(GO:0060126) |
0.2 | 0.2 | GO:0015846 | protein catabolic process in the vacuole(GO:0007039) polyamine transport(GO:0015846) |
0.2 | 0.3 | GO:0043616 | keratinocyte proliferation(GO:0043616) |
0.2 | 0.2 | GO:0090520 | sphingolipid mediated signaling pathway(GO:0090520) |
0.2 | 1.3 | GO:0042246 | tissue regeneration(GO:0042246) |
0.2 | 0.5 | GO:0071772 | response to BMP(GO:0071772) cellular response to BMP stimulus(GO:0071773) |
0.2 | 0.2 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.2 | 0.5 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.2 | 0.2 | GO:0002765 | immune response-inhibiting signal transduction(GO:0002765) |
0.2 | 0.2 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
0.2 | 0.3 | GO:0051354 | negative regulation of oxidoreductase activity(GO:0051354) |
0.2 | 0.2 | GO:0098739 | import across plasma membrane(GO:0098739) |
0.2 | 0.3 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.2 | 0.8 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.2 | 2.1 | GO:0050680 | negative regulation of epithelial cell proliferation(GO:0050680) |
0.2 | 1.3 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.2 | 1.1 | GO:0007528 | neuromuscular junction development(GO:0007528) |
0.2 | 2.0 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.2 | 0.5 | GO:0007141 | male meiosis I(GO:0007141) |
0.2 | 0.2 | GO:0006700 | C21-steroid hormone biosynthetic process(GO:0006700) |
0.2 | 0.6 | GO:0045577 | regulation of B cell differentiation(GO:0045577) |
0.2 | 0.5 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.2 | 2.5 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.2 | 0.3 | GO:0003351 | epithelial cilium movement(GO:0003351) |
0.2 | 0.2 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.2 | 0.3 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
0.1 | 1.2 | GO:0031032 | actomyosin structure organization(GO:0031032) |
0.1 | 0.4 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.1 | 0.3 | GO:0048102 | autophagic cell death(GO:0048102) |
0.1 | 1.0 | GO:0032814 | regulation of natural killer cell activation(GO:0032814) |
0.1 | 0.1 | GO:0051709 | regulation of killing of cells of other organism(GO:0051709) positive regulation of killing of cells of other organism(GO:0051712) |
0.1 | 0.7 | GO:0001782 | B cell homeostasis(GO:0001782) |
0.1 | 1.9 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
0.1 | 0.4 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) |
0.1 | 0.1 | GO:0001975 | response to amphetamine(GO:0001975) |
0.1 | 0.1 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.1 | 0.7 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
0.1 | 0.1 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.1 | 0.3 | GO:0002578 | negative regulation of antigen processing and presentation(GO:0002578) negative regulation of antigen processing and presentation of peptide antigen(GO:0002584) |
0.1 | 0.1 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.1 | 1.0 | GO:0046051 | UTP metabolic process(GO:0046051) |
0.1 | 0.1 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.1 | 0.1 | GO:0019374 | galactolipid metabolic process(GO:0019374) |
0.1 | 0.1 | GO:0033599 | regulation of mammary gland epithelial cell proliferation(GO:0033599) |
0.1 | 0.4 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.1 | 0.1 | GO:0046886 | positive regulation of hormone biosynthetic process(GO:0046886) |
0.1 | 0.3 | GO:0033227 | dsRNA transport(GO:0033227) |
0.1 | 0.1 | GO:0045911 | positive regulation of DNA recombination(GO:0045911) |
0.1 | 0.4 | GO:1900060 | negative regulation of ceramide biosynthetic process(GO:1900060) |
0.1 | 0.1 | GO:0033762 | response to glucagon(GO:0033762) |
0.1 | 1.2 | GO:0001913 | T cell mediated cytotoxicity(GO:0001913) |
0.1 | 0.4 | GO:0015747 | urate transport(GO:0015747) |
0.1 | 0.4 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.1 | 0.1 | GO:0002328 | pro-B cell differentiation(GO:0002328) |
0.1 | 0.8 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.1 | 1.2 | GO:1902017 | regulation of cilium assembly(GO:1902017) |
0.1 | 0.1 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.1 | 3.1 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
0.1 | 0.3 | GO:0070129 | regulation of mitochondrial translation(GO:0070129) |
0.1 | 0.1 | GO:1903772 | regulation of viral budding via host ESCRT complex(GO:1903772) |
0.1 | 3.7 | GO:0007160 | cell-matrix adhesion(GO:0007160) |
0.1 | 0.5 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.1 | 0.2 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.1 | 0.1 | GO:0042481 | regulation of odontogenesis(GO:0042481) |
0.1 | 0.1 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
0.1 | 0.6 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.1 | 0.2 | GO:0019184 | nonribosomal peptide biosynthetic process(GO:0019184) |
0.1 | 0.2 | GO:0014046 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.1 | 0.5 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.1 | 0.1 | GO:0003094 | glomerular filtration(GO:0003094) |
0.1 | 1.0 | GO:0071875 | adrenergic receptor signaling pathway(GO:0071875) |
0.1 | 0.2 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.1 | 0.1 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.1 | 0.2 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.1 | 0.2 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.1 | 0.2 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.1 | 0.5 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.1 | 0.2 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.1 | 0.4 | GO:0033572 | transferrin transport(GO:0033572) |
0.1 | 0.1 | GO:1901374 | acetylcholine transport(GO:0015870) acetate ester transport(GO:1901374) |
0.1 | 0.4 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.1 | 0.1 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
0.1 | 0.1 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
0.1 | 0.2 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.1 | 2.2 | GO:0009855 | specification of symmetry(GO:0009799) determination of bilateral symmetry(GO:0009855) |
0.1 | 0.8 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.1 | 0.1 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
0.1 | 0.8 | GO:0052697 | xenobiotic glucuronidation(GO:0052697) |
0.1 | 0.3 | GO:1900004 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.1 | 0.3 | GO:0051013 | microtubule severing(GO:0051013) |
0.1 | 0.5 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.1 | 0.3 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.1 | 0.3 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
0.1 | 0.1 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.1 | 0.5 | GO:0071168 | protein localization to chromatin(GO:0071168) |
0.1 | 0.1 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.1 | 0.2 | GO:0097028 | dendritic cell differentiation(GO:0097028) |
0.1 | 0.1 | GO:0097066 | response to thyroid hormone(GO:0097066) |
0.1 | 0.1 | GO:0010934 | macrophage cytokine production(GO:0010934) |
0.1 | 0.4 | GO:1903361 | maintenance of epithelial cell apical/basal polarity(GO:0045199) protein localization to basolateral plasma membrane(GO:1903361) |
0.1 | 0.1 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.1 | 0.3 | GO:0010528 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.1 | 2.6 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.1 | 0.2 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.1 | 0.3 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.1 | 0.1 | GO:0009111 | vitamin catabolic process(GO:0009111) fat-soluble vitamin catabolic process(GO:0042363) |
0.1 | 0.2 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.1 | 0.1 | GO:1900109 | regulation of histone H3-K9 dimethylation(GO:1900109) |
0.1 | 0.1 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.1 | 0.2 | GO:0000270 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
0.1 | 0.1 | GO:0019730 | antimicrobial humoral response(GO:0019730) |
0.1 | 2.2 | GO:0032526 | response to retinoic acid(GO:0032526) |
0.1 | 0.2 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.1 | 0.1 | GO:0044851 | hair cycle phase(GO:0044851) |
0.1 | 0.1 | GO:2000327 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.1 | 0.1 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.1 | 0.1 | GO:0071971 | extracellular exosome assembly(GO:0071971) |
0.1 | 0.1 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.1 | 0.2 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.1 | 0.4 | GO:0046889 | positive regulation of lipid biosynthetic process(GO:0046889) |
0.1 | 0.1 | GO:0035935 | androgen secretion(GO:0035935) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) |
0.1 | 0.6 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.1 | 0.3 | GO:0050995 | negative regulation of lipid catabolic process(GO:0050995) |
0.1 | 0.2 | GO:0009125 | nucleoside monophosphate catabolic process(GO:0009125) |
0.1 | 0.4 | GO:0042984 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.1 | 1.4 | GO:0042303 | molting cycle(GO:0042303) hair cycle(GO:0042633) |
0.1 | 0.1 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.1 | 0.8 | GO:0002902 | regulation of B cell apoptotic process(GO:0002902) |
0.1 | 1.2 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
0.1 | 0.1 | GO:0051154 | negative regulation of striated muscle cell differentiation(GO:0051154) |
0.1 | 0.5 | GO:0015695 | organic cation transport(GO:0015695) |
0.1 | 0.1 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.1 | 0.4 | GO:0051974 | negative regulation of telomerase activity(GO:0051974) |
0.1 | 0.4 | GO:0003254 | regulation of membrane depolarization(GO:0003254) |
0.1 | 0.1 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
0.1 | 0.1 | GO:0010390 | histone monoubiquitination(GO:0010390) |
0.1 | 0.4 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.1 | 0.2 | GO:0040020 | regulation of meiotic nuclear division(GO:0040020) |
0.1 | 0.1 | GO:0010092 | specification of organ identity(GO:0010092) |
0.1 | 0.2 | GO:0032732 | positive regulation of interleukin-1 production(GO:0032732) |
0.1 | 0.6 | GO:1902042 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902042) |
0.1 | 0.1 | GO:1901142 | insulin metabolic process(GO:1901142) |
0.1 | 0.2 | GO:0001658 | branching involved in ureteric bud morphogenesis(GO:0001658) |
0.1 | 0.2 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
0.1 | 0.1 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
0.1 | 0.1 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
0.1 | 0.2 | GO:0000957 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.1 | 0.4 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
0.1 | 0.1 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
0.1 | 0.3 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
0.1 | 0.1 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.1 | 0.1 | GO:2000398 | regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
0.1 | 0.3 | GO:0045806 | negative regulation of endocytosis(GO:0045806) |
0.1 | 5.5 | GO:0071230 | cellular response to amino acid stimulus(GO:0071230) |
0.1 | 0.1 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.1 | 0.1 | GO:0051446 | positive regulation of meiotic cell cycle(GO:0051446) |
0.1 | 0.3 | GO:0046110 | xanthine metabolic process(GO:0046110) |
0.1 | 0.1 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.1 | 0.1 | GO:0010869 | regulation of receptor biosynthetic process(GO:0010869) |
0.1 | 0.2 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.1 | 0.1 | GO:0002678 | positive regulation of chronic inflammatory response(GO:0002678) |
0.1 | 0.2 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) |
0.1 | 0.1 | GO:0016045 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
0.1 | 0.1 | GO:0033684 | regulation of luteinizing hormone secretion(GO:0033684) |
0.1 | 0.1 | GO:0010635 | regulation of mitochondrial fusion(GO:0010635) |
0.1 | 0.3 | GO:0006415 | translational termination(GO:0006415) |
0.1 | 0.1 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.1 | 0.1 | GO:0043032 | positive regulation of macrophage activation(GO:0043032) |
0.1 | 0.1 | GO:1903441 | protein localization to ciliary membrane(GO:1903441) |
0.1 | 0.2 | GO:0055090 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.1 | 0.1 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.1 | 0.1 | GO:2000535 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.1 | 0.1 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
0.1 | 0.1 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.1 | 0.1 | GO:0033280 | response to vitamin D(GO:0033280) |
0.1 | 0.1 | GO:0015874 | norepinephrine transport(GO:0015874) |
0.1 | 0.1 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.1 | 0.1 | GO:0014045 | establishment of endothelial blood-brain barrier(GO:0014045) |
0.1 | 0.1 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.1 | 0.3 | GO:0072595 | maintenance of protein localization in organelle(GO:0072595) |
0.1 | 0.2 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.1 | 0.1 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
0.1 | 0.1 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.1 | 0.2 | GO:0031670 | cellular response to nutrient(GO:0031670) |
0.1 | 0.1 | GO:0036124 | histone H3-K9 trimethylation(GO:0036124) |
0.1 | 0.3 | GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
0.1 | 0.1 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.1 | 0.2 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.1 | 0.2 | GO:0039703 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.0 | 0.3 | GO:0044705 | mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
0.0 | 0.0 | GO:0033151 | V(D)J recombination(GO:0033151) |
0.0 | 0.0 | GO:0034756 | regulation of iron ion transport(GO:0034756) |
0.0 | 0.7 | GO:0090662 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.0 | 0.4 | GO:0006721 | terpenoid metabolic process(GO:0006721) |
0.0 | 0.4 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.0 | 0.0 | GO:0042939 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
0.0 | 0.1 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.0 | 0.1 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.0 | 0.4 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.0 | 0.0 | GO:1901185 | negative regulation of ERBB signaling pathway(GO:1901185) |
0.0 | 0.0 | GO:0060969 | negative regulation of gene silencing(GO:0060969) |
0.0 | 0.2 | GO:0014823 | response to activity(GO:0014823) |
0.0 | 0.0 | GO:0072148 | epithelial cell fate commitment(GO:0072148) |
0.0 | 0.0 | GO:0021898 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
0.0 | 1.0 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.0 | 0.0 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.0 | 0.1 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.0 | 0.1 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.0 | 0.2 | GO:0014047 | glutamate secretion(GO:0014047) |
0.0 | 1.6 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.0 | 0.1 | GO:0046689 | response to mercury ion(GO:0046689) |
0.0 | 0.1 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.0 | 0.0 | GO:1901894 | regulation of calcium-transporting ATPase activity(GO:1901894) |
0.0 | 0.0 | GO:0045061 | thymic T cell selection(GO:0045061) |
0.0 | 0.0 | GO:0090289 | regulation of osteoclast proliferation(GO:0090289) |
0.0 | 0.0 | GO:0032252 | secretory granule localization(GO:0032252) |
0.0 | 0.0 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.0 | 0.1 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
0.0 | 0.5 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.0 | 0.1 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
0.0 | 0.0 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
0.0 | 0.0 | GO:0045652 | regulation of megakaryocyte differentiation(GO:0045652) |
0.0 | 0.3 | GO:0045687 | positive regulation of glial cell differentiation(GO:0045687) |
0.0 | 0.3 | GO:1903313 | positive regulation of mRNA metabolic process(GO:1903313) |
0.0 | 0.0 | GO:0009838 | abscission(GO:0009838) |
0.0 | 0.0 | GO:0034695 | response to prostaglandin E(GO:0034695) |
0.0 | 0.1 | GO:0051004 | regulation of lipoprotein lipase activity(GO:0051004) |
0.0 | 0.1 | GO:1903232 | melanosome assembly(GO:1903232) |
0.0 | 0.7 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.0 | 0.1 | GO:0006098 | pentose-phosphate shunt(GO:0006098) |
0.0 | 0.1 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.0 | 0.1 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.0 | 0.0 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.0 | 0.6 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
0.0 | 0.5 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.0 | 28.6 | GO:0007608 | sensory perception of smell(GO:0007608) |
0.0 | 0.0 | GO:0016078 | tRNA catabolic process(GO:0016078) |
0.0 | 0.1 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
0.0 | 0.7 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.0 | 0.7 | GO:0045727 | positive regulation of translation(GO:0045727) |
0.0 | 0.1 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.0 | 0.3 | GO:0006414 | translational elongation(GO:0006414) |
0.0 | 0.0 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
0.0 | 0.2 | GO:1901663 | quinone biosynthetic process(GO:1901663) |
0.0 | 0.0 | GO:0035188 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.0 | 0.0 | GO:0033144 | negative regulation of intracellular steroid hormone receptor signaling pathway(GO:0033144) |
0.0 | 0.6 | GO:0030216 | keratinocyte differentiation(GO:0030216) |
0.0 | 0.1 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.0 | 0.0 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.0 | 0.0 | GO:0035196 | production of miRNAs involved in gene silencing by miRNA(GO:0035196) |
0.0 | 0.1 | GO:1902600 | hydrogen ion transmembrane transport(GO:1902600) |
0.0 | 0.0 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.0 | 0.0 | GO:0035878 | nail development(GO:0035878) |
0.0 | 0.0 | GO:0046851 | negative regulation of bone resorption(GO:0045779) negative regulation of bone remodeling(GO:0046851) |
0.0 | 0.0 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.0 | 0.0 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.0 | 0.0 | GO:0021602 | cranial nerve morphogenesis(GO:0021602) |
0.0 | 0.0 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.0 | 0.0 | GO:0034382 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
0.0 | 0.0 | GO:0051156 | glucose 6-phosphate metabolic process(GO:0051156) |
0.0 | 0.0 | GO:0032459 | regulation of protein oligomerization(GO:0032459) |
0.0 | 0.0 | GO:0009146 | purine nucleoside triphosphate catabolic process(GO:0009146) |
0.0 | 0.0 | GO:0060923 | cardiac muscle cell fate commitment(GO:0060923) |
0.0 | 0.0 | GO:0030238 | male sex determination(GO:0030238) |
0.0 | 0.0 | GO:1901662 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.0 | 0.0 | GO:0010587 | miRNA catabolic process(GO:0010587) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
8.2 | 48.9 | GO:0098642 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
7.6 | 45.6 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
7.2 | 57.4 | GO:0005861 | troponin complex(GO:0005861) |
6.1 | 24.3 | GO:0005610 | laminin-5 complex(GO:0005610) |
6.0 | 24.1 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
5.5 | 16.4 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
5.4 | 48.6 | GO:0005859 | muscle myosin complex(GO:0005859) |
5.1 | 15.2 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
4.5 | 27.1 | GO:0045180 | basal cortex(GO:0045180) |
4.4 | 48.1 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
3.9 | 11.8 | GO:0097427 | microtubule bundle(GO:0097427) |
3.7 | 3.7 | GO:0016328 | lateral plasma membrane(GO:0016328) |
3.7 | 21.9 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
3.6 | 14.6 | GO:0000125 | PCAF complex(GO:0000125) |
3.6 | 14.5 | GO:0071953 | elastic fiber(GO:0071953) |
3.5 | 28.1 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
3.5 | 10.4 | GO:0097513 | myosin II filament(GO:0097513) |
3.4 | 13.5 | GO:0030478 | actin cap(GO:0030478) |
3.4 | 30.3 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
3.3 | 46.2 | GO:0036379 | myofilament(GO:0036379) |
3.1 | 12.6 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
3.1 | 12.5 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
3.1 | 24.9 | GO:0045179 | apical cortex(GO:0045179) |
3.1 | 166.4 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
3.0 | 6.1 | GO:0043259 | laminin-10 complex(GO:0043259) |
3.0 | 12.0 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
3.0 | 18.0 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
2.9 | 41.1 | GO:0031430 | M band(GO:0031430) |
2.9 | 26.1 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
2.7 | 10.9 | GO:0070545 | PeBoW complex(GO:0070545) |
2.7 | 43.6 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
2.6 | 41.8 | GO:0031672 | A band(GO:0031672) |
2.6 | 2.6 | GO:0032994 | protein-lipid complex(GO:0032994) |
2.6 | 2.6 | GO:0035861 | site of double-strand break(GO:0035861) |
2.6 | 5.1 | GO:0005608 | laminin-3 complex(GO:0005608) |
2.5 | 10.2 | GO:0071203 | WASH complex(GO:0071203) |
2.5 | 2.5 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
2.3 | 11.7 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
2.3 | 9.3 | GO:0000938 | GARP complex(GO:0000938) |
2.3 | 4.5 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
2.2 | 13.5 | GO:0032982 | myosin filament(GO:0032982) |
2.2 | 17.8 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
2.2 | 4.4 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
2.2 | 21.7 | GO:0016600 | flotillin complex(GO:0016600) |
2.1 | 14.8 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
2.0 | 2.0 | GO:0060076 | excitatory synapse(GO:0060076) |
2.0 | 11.9 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
2.0 | 3.9 | GO:0005955 | calcineurin complex(GO:0005955) |
1.9 | 1.9 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
1.9 | 22.4 | GO:0000118 | histone deacetylase complex(GO:0000118) |
1.8 | 5.5 | GO:0016235 | aggresome(GO:0016235) |
1.8 | 1.8 | GO:0097539 | ciliary transition fiber(GO:0097539) |
1.8 | 1.8 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
1.8 | 27.0 | GO:0034706 | sodium channel complex(GO:0034706) |
1.8 | 1.8 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
1.8 | 5.4 | GO:0070765 | gamma-secretase complex(GO:0070765) |
1.8 | 17.8 | GO:0005916 | fascia adherens(GO:0005916) |
1.8 | 3.6 | GO:0005914 | spot adherens junction(GO:0005914) |
1.7 | 10.4 | GO:0043219 | lateral loop(GO:0043219) |
1.7 | 27.8 | GO:0005614 | interstitial matrix(GO:0005614) |
1.7 | 6.9 | GO:0071141 | SMAD protein complex(GO:0071141) |
1.7 | 5.1 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
1.7 | 5.0 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
1.7 | 1.7 | GO:0031528 | microvillus membrane(GO:0031528) |
1.7 | 6.6 | GO:0005915 | zonula adherens(GO:0005915) |
1.7 | 14.9 | GO:0043034 | costamere(GO:0043034) |
1.6 | 26.2 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
1.6 | 1.6 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
1.6 | 3.2 | GO:0044299 | C-fiber(GO:0044299) |
1.6 | 1.6 | GO:0035061 | interchromatin granule(GO:0035061) |
1.5 | 9.3 | GO:0030314 | junctional membrane complex(GO:0030314) |
1.5 | 6.2 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
1.5 | 9.3 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
1.5 | 39.2 | GO:0008305 | integrin complex(GO:0008305) |
1.5 | 42.0 | GO:0055038 | recycling endosome membrane(GO:0055038) |
1.5 | 12.0 | GO:0070578 | RISC-loading complex(GO:0070578) |
1.5 | 4.4 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
1.5 | 85.8 | GO:0031674 | I band(GO:0031674) |
1.5 | 4.4 | GO:0005588 | collagen type V trimer(GO:0005588) |
1.5 | 1.5 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
1.5 | 14.6 | GO:0060091 | kinocilium(GO:0060091) |
1.5 | 5.8 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
1.5 | 8.7 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
1.4 | 4.3 | GO:0030027 | lamellipodium(GO:0030027) |
1.4 | 2.8 | GO:0031258 | lamellipodium membrane(GO:0031258) |
1.4 | 11.2 | GO:0031143 | pseudopodium(GO:0031143) |
1.4 | 4.2 | GO:0016342 | catenin complex(GO:0016342) |
1.4 | 4.2 | GO:0097443 | sorting endosome(GO:0097443) |
1.4 | 26.5 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
1.4 | 7.0 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
1.4 | 12.5 | GO:0097208 | alveolar lamellar body(GO:0097208) |
1.4 | 20.6 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
1.4 | 15.0 | GO:0005605 | basal lamina(GO:0005605) |
1.3 | 6.7 | GO:0033270 | paranode region of axon(GO:0033270) |
1.3 | 4.0 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
1.3 | 15.8 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
1.3 | 2.6 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
1.3 | 11.5 | GO:0030061 | mitochondrial crista(GO:0030061) |
1.3 | 10.2 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
1.3 | 20.2 | GO:0000145 | exocyst(GO:0000145) |
1.3 | 16.4 | GO:0097431 | mitotic spindle pole(GO:0097431) |
1.3 | 8.8 | GO:0043083 | synaptic cleft(GO:0043083) |
1.2 | 17.4 | GO:0043196 | varicosity(GO:0043196) |
1.2 | 6.2 | GO:0005827 | polar microtubule(GO:0005827) |
1.2 | 4.9 | GO:0032585 | multivesicular body membrane(GO:0032585) |
1.2 | 314.5 | GO:0005925 | focal adhesion(GO:0005925) |
1.2 | 6.0 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
1.2 | 36.8 | GO:0005581 | collagen trimer(GO:0005581) |
1.2 | 7.1 | GO:0072687 | meiotic spindle(GO:0072687) |
1.2 | 15.2 | GO:0016514 | SWI/SNF complex(GO:0016514) |
1.2 | 5.8 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
1.2 | 4.7 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
1.1 | 3.4 | GO:0032584 | growth cone membrane(GO:0032584) |
1.1 | 12.5 | GO:0035102 | PRC1 complex(GO:0035102) |
1.1 | 2.3 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
1.1 | 3.4 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
1.1 | 71.7 | GO:0042383 | sarcolemma(GO:0042383) |
1.1 | 2.2 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
1.1 | 3.2 | GO:0070939 | Dsl1p complex(GO:0070939) |
1.1 | 2.1 | GO:0070852 | cell body fiber(GO:0070852) |
1.1 | 9.6 | GO:0097470 | ribbon synapse(GO:0097470) |
1.1 | 7.5 | GO:0042587 | glycogen granule(GO:0042587) |
1.1 | 2.1 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
1.0 | 6.3 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
1.0 | 44.0 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
1.0 | 1.0 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
1.0 | 3.1 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
1.0 | 1.0 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
1.0 | 9.3 | GO:0005869 | dynactin complex(GO:0005869) |
1.0 | 3.1 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
1.0 | 4.1 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
1.0 | 5.1 | GO:0031983 | vesicle lumen(GO:0031983) |
1.0 | 5.1 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
1.0 | 3.1 | GO:0005879 | axonemal microtubule(GO:0005879) |
1.0 | 1.0 | GO:0000242 | pericentriolar material(GO:0000242) |
1.0 | 59.4 | GO:0005604 | basement membrane(GO:0005604) |
1.0 | 19.1 | GO:0030016 | myofibril(GO:0030016) |
1.0 | 3.0 | GO:0044316 | cone cell pedicle(GO:0044316) |
1.0 | 2.9 | GO:0005712 | chiasma(GO:0005712) |
1.0 | 6.8 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
1.0 | 2.9 | GO:0042583 | chromaffin granule(GO:0042583) |
1.0 | 1.9 | GO:0001739 | sex chromatin(GO:0001739) |
0.9 | 51.2 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.9 | 4.7 | GO:0032009 | early phagosome(GO:0032009) |
0.9 | 5.5 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.9 | 7.2 | GO:0036157 | outer dynein arm(GO:0036157) |
0.9 | 23.8 | GO:0031901 | early endosome membrane(GO:0031901) |
0.9 | 7.1 | GO:0000812 | Swr1 complex(GO:0000812) |
0.9 | 8.7 | GO:0043218 | compact myelin(GO:0043218) |
0.9 | 2.6 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.9 | 12.1 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.9 | 0.9 | GO:0030313 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.9 | 11.1 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.9 | 18.8 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.9 | 7.7 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.8 | 22.7 | GO:0016459 | myosin complex(GO:0016459) |
0.8 | 205.9 | GO:0031012 | extracellular matrix(GO:0031012) |
0.8 | 10.9 | GO:0046930 | pore complex(GO:0046930) |
0.8 | 5.8 | GO:0030008 | TRAPP complex(GO:0030008) |
0.8 | 3.3 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.8 | 4.1 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.8 | 3.2 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.8 | 3.2 | GO:0097651 | phosphatidylinositol 3-kinase complex, class I(GO:0097651) |
0.8 | 0.8 | GO:0043203 | axon hillock(GO:0043203) |
0.8 | 0.8 | GO:0030666 | endocytic vesicle membrane(GO:0030666) clathrin-coated endocytic vesicle membrane(GO:0030669) |
0.8 | 2.4 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.8 | 3.2 | GO:0042629 | mast cell granule(GO:0042629) |
0.8 | 14.2 | GO:0045202 | synapse(GO:0045202) |
0.8 | 4.7 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.8 | 3.1 | GO:0098589 | membrane region(GO:0098589) |
0.8 | 1.5 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.8 | 0.8 | GO:0034703 | cation channel complex(GO:0034703) |
0.8 | 11.5 | GO:0097225 | sperm midpiece(GO:0097225) |
0.8 | 0.8 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.8 | 2.3 | GO:0097413 | Lewy body(GO:0097413) |
0.7 | 2.2 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
0.7 | 38.9 | GO:0005811 | lipid particle(GO:0005811) |
0.7 | 0.7 | GO:1902710 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.7 | 1.5 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.7 | 2.2 | GO:0071439 | clathrin complex(GO:0071439) |
0.7 | 1.5 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.7 | 11.5 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.7 | 2.2 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.7 | 1.4 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.7 | 2.2 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.7 | 5.0 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.7 | 38.1 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.7 | 65.0 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
0.7 | 3.5 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.7 | 0.7 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.7 | 0.7 | GO:0032432 | actin filament bundle(GO:0032432) |
0.7 | 7.0 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.7 | 2.7 | GO:0045298 | tubulin complex(GO:0045298) |
0.7 | 2.0 | GO:1990393 | 3M complex(GO:1990393) |
0.7 | 1.4 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.7 | 2.7 | GO:0001520 | outer dense fiber(GO:0001520) |
0.7 | 2.6 | GO:0070820 | tertiary granule(GO:0070820) |
0.7 | 5.9 | GO:0030914 | STAGA complex(GO:0030914) |
0.7 | 2.6 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.7 | 0.7 | GO:0030055 | cell-substrate junction(GO:0030055) |
0.6 | 6.5 | GO:0043657 | host(GO:0018995) host cell part(GO:0033643) host cell(GO:0043657) |
0.6 | 7.1 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.6 | 1.3 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
0.6 | 27.5 | GO:0005912 | adherens junction(GO:0005912) |
0.6 | 18.5 | GO:0005921 | gap junction(GO:0005921) |
0.6 | 14.6 | GO:0045121 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.6 | 2.5 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.6 | 8.8 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.6 | 3.2 | GO:0016580 | Sin3 complex(GO:0016580) |
0.6 | 16.9 | GO:0031519 | PcG protein complex(GO:0031519) |
0.6 | 5.6 | GO:0031045 | dense core granule(GO:0031045) |
0.6 | 0.6 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.6 | 3.7 | GO:0033263 | CORVET complex(GO:0033263) |
0.6 | 13.0 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.6 | 0.6 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.6 | 26.5 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.6 | 5.4 | GO:0033177 | proton-transporting two-sector ATPase complex, proton-transporting domain(GO:0033177) proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
0.6 | 3.0 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.6 | 14.9 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.6 | 4.2 | GO:0016272 | prefoldin complex(GO:0016272) |
0.6 | 9.5 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.6 | 0.6 | GO:1903349 | omegasome membrane(GO:1903349) |
0.6 | 3.5 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.6 | 0.6 | GO:0030684 | preribosome(GO:0030684) |
0.6 | 2.3 | GO:0044194 | cytolytic granule(GO:0044194) |
0.6 | 2.9 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.6 | 3.4 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.6 | 179.4 | GO:0005667 | transcription factor complex(GO:0005667) |
0.6 | 25.6 | GO:0031526 | brush border membrane(GO:0031526) |
0.6 | 8.8 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.6 | 12.1 | GO:0000795 | synaptonemal complex(GO:0000795) |
0.5 | 1.1 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.5 | 1.6 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
0.5 | 1.6 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.5 | 2.7 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.5 | 6.0 | GO:0033202 | DNA helicase complex(GO:0033202) |
0.5 | 1.6 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.5 | 15.5 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.5 | 2.7 | GO:0071547 | piP-body(GO:0071547) |
0.5 | 5.9 | GO:0010369 | chromocenter(GO:0010369) |
0.5 | 0.5 | GO:0044327 | dendritic spine head(GO:0044327) |
0.5 | 1.0 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.5 | 6.1 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.5 | 2.5 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.5 | 48.2 | GO:0005882 | intermediate filament(GO:0005882) |
0.5 | 1.5 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.5 | 3.0 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.5 | 3.0 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.5 | 1.5 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.5 | 2.4 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.5 | 1.4 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.5 | 3.8 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.5 | 2.9 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.5 | 47.1 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.5 | 14.7 | GO:0045171 | intercellular bridge(GO:0045171) |
0.5 | 4.2 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.5 | 3.3 | GO:0002102 | podosome(GO:0002102) |
0.5 | 0.9 | GO:1990923 | PET complex(GO:1990923) |
0.5 | 1.9 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.5 | 9.3 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.5 | 0.5 | GO:0030870 | Mre11 complex(GO:0030870) |
0.5 | 0.5 | GO:0016939 | kinesin II complex(GO:0016939) |
0.4 | 4.0 | GO:0030175 | filopodium(GO:0030175) |
0.4 | 1.3 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.4 | 1.8 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
0.4 | 5.3 | GO:0030663 | COPI-coated vesicle membrane(GO:0030663) |
0.4 | 0.9 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.4 | 26.9 | GO:0043296 | apical junction complex(GO:0043296) |
0.4 | 4.3 | GO:0034451 | centriolar satellite(GO:0034451) |
0.4 | 8.2 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.4 | 1.7 | GO:0035363 | histone locus body(GO:0035363) |
0.4 | 1.3 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.4 | 1.7 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.4 | 1.6 | GO:0043292 | contractile fiber(GO:0043292) |
0.4 | 1.2 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.4 | 8.1 | GO:0005903 | brush border(GO:0005903) |
0.4 | 4.0 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.4 | 1.2 | GO:0061617 | MICOS complex(GO:0061617) |
0.4 | 2.0 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.4 | 0.4 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.4 | 8.9 | GO:0031985 | Golgi cisterna(GO:0031985) |
0.4 | 0.8 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.4 | 3.9 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.4 | 2.7 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.4 | 2.7 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.4 | 2.3 | GO:0001741 | XY body(GO:0001741) |
0.4 | 3.0 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.4 | 1.9 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.4 | 11.7 | GO:0043204 | perikaryon(GO:0043204) |
0.4 | 1.5 | GO:0001891 | phagocytic cup(GO:0001891) |
0.4 | 1.1 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.4 | 33.8 | GO:0015629 | actin cytoskeleton(GO:0015629) |
0.4 | 3.3 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.4 | 1.1 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.4 | 344.3 | GO:0005615 | extracellular space(GO:0005615) |
0.4 | 7.2 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.4 | 0.7 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.4 | 4.3 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.4 | 0.4 | GO:0044292 | dendrite terminus(GO:0044292) |
0.3 | 3.1 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.3 | 1.0 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.3 | 38.6 | GO:0031965 | nuclear membrane(GO:0031965) |
0.3 | 1.0 | GO:0000791 | euchromatin(GO:0000791) |
0.3 | 1.0 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.3 | 2.7 | GO:0000243 | commitment complex(GO:0000243) |
0.3 | 9.9 | GO:0005884 | actin filament(GO:0005884) |
0.3 | 2.0 | GO:0001726 | ruffle(GO:0001726) |
0.3 | 1.3 | GO:0031252 | cell leading edge(GO:0031252) |
0.3 | 0.7 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.3 | 3.2 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.3 | 17.6 | GO:0010008 | endosome membrane(GO:0010008) |
0.3 | 8.4 | GO:0005814 | centriole(GO:0005814) |
0.3 | 0.6 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.3 | 4.9 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.3 | 9.5 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.3 | 0.9 | GO:0097441 | basilar dendrite(GO:0097441) |
0.3 | 0.6 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
0.3 | 6.5 | GO:0005901 | caveola(GO:0005901) |
0.3 | 3.2 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.3 | 9.6 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.3 | 4.0 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
0.3 | 2.0 | GO:0030673 | axolemma(GO:0030673) |
0.3 | 3.9 | GO:0030686 | 90S preribosome(GO:0030686) |
0.3 | 1.1 | GO:0071797 | LUBAC complex(GO:0071797) |
0.3 | 1.4 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.3 | 0.8 | GO:0005796 | Golgi lumen(GO:0005796) |
0.3 | 1.6 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.3 | 0.5 | GO:0000785 | chromatin(GO:0000785) |
0.3 | 1.6 | GO:0097440 | apical dendrite(GO:0097440) |
0.3 | 0.5 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.3 | 2.1 | GO:0070652 | HAUS complex(GO:0070652) |
0.3 | 1.1 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.3 | 1.6 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.3 | 0.8 | GO:0097255 | R2TP complex(GO:0097255) |
0.3 | 0.3 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
0.3 | 1.0 | GO:0035339 | SPOTS complex(GO:0035339) |
0.3 | 2.3 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.3 | 3.8 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.3 | 1.3 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.2 | 3.2 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.2 | 4.0 | GO:0030990 | intraciliary transport particle(GO:0030990) |
0.2 | 7.2 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.2 | 2.5 | GO:0000346 | transcription export complex(GO:0000346) |
0.2 | 1.5 | GO:0005688 | U6 snRNP(GO:0005688) |
0.2 | 1.0 | GO:0030897 | HOPS complex(GO:0030897) |
0.2 | 14.6 | GO:0030427 | site of polarized growth(GO:0030427) |
0.2 | 0.7 | GO:0070552 | BRISC complex(GO:0070552) |
0.2 | 15.7 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.2 | 1.9 | GO:0036128 | CatSper complex(GO:0036128) |
0.2 | 0.2 | GO:1990423 | RZZ complex(GO:1990423) |
0.2 | 56.9 | GO:0030054 | cell junction(GO:0030054) |
0.2 | 1.8 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.2 | 0.7 | GO:0043293 | apoptosome(GO:0043293) |
0.2 | 4.3 | GO:0043235 | receptor complex(GO:0043235) |
0.2 | 0.2 | GO:0098862 | cluster of actin-based cell projections(GO:0098862) |
0.2 | 1.6 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.2 | 3.1 | GO:0005682 | U5 snRNP(GO:0005682) |
0.2 | 1.6 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.2 | 0.7 | GO:0097422 | tubular endosome(GO:0097422) |
0.2 | 0.6 | GO:0005745 | m-AAA complex(GO:0005745) |
0.2 | 0.4 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.2 | 0.2 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.2 | 0.2 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) |
0.2 | 1.3 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.2 | 0.6 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
0.2 | 2.5 | GO:0098858 | actin-based cell projection(GO:0098858) |
0.2 | 0.6 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.2 | 0.4 | GO:0051286 | cell tip(GO:0051286) |
0.2 | 0.4 | GO:0031201 | SNARE complex(GO:0031201) |
0.2 | 5.2 | GO:0030496 | midbody(GO:0030496) |
0.2 | 1.8 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.2 | 0.6 | GO:0001652 | granular component(GO:0001652) |
0.2 | 0.6 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.2 | 0.6 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.2 | 1.7 | GO:0005858 | axonemal dynein complex(GO:0005858) inner dynein arm(GO:0036156) |
0.2 | 3.6 | GO:0005871 | kinesin complex(GO:0005871) |
0.2 | 0.4 | GO:0031931 | TORC1 complex(GO:0031931) |
0.2 | 0.8 | GO:0030904 | retromer complex(GO:0030904) |
0.2 | 3.4 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.2 | 1.5 | GO:0000792 | heterochromatin(GO:0000792) |
0.2 | 0.6 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.2 | 0.2 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.2 | 0.6 | GO:0016589 | NURF complex(GO:0016589) |
0.2 | 0.5 | GO:0031417 | NatC complex(GO:0031417) |
0.2 | 4.8 | GO:0030964 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.2 | 0.5 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.2 | 0.4 | GO:0005652 | nuclear lamina(GO:0005652) |
0.2 | 3.1 | GO:0000786 | nucleosome(GO:0000786) |
0.2 | 0.8 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.2 | 0.3 | GO:1990635 | proximal dendrite(GO:1990635) |
0.2 | 0.7 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.2 | 0.5 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.2 | 2.3 | GO:0031231 | intrinsic component of peroxisomal membrane(GO:0031231) |
0.2 | 0.8 | GO:0048500 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.2 | 10.8 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.2 | 4.5 | GO:0005844 | polysome(GO:0005844) |
0.2 | 2.3 | GO:0032587 | ruffle membrane(GO:0032587) |
0.2 | 0.2 | GO:0005642 | annulate lamellae(GO:0005642) |
0.2 | 1.6 | GO:0036038 | MKS complex(GO:0036038) |
0.2 | 0.5 | GO:0048179 | activin receptor complex(GO:0048179) |
0.2 | 2.0 | GO:0005684 | U2-type spliceosomal complex(GO:0005684) |
0.2 | 1.1 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.1 | 120.8 | GO:0031226 | intrinsic component of plasma membrane(GO:0031226) |
0.1 | 0.6 | GO:0072487 | MSL complex(GO:0072487) |
0.1 | 8.5 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.1 | 0.1 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.1 | 0.6 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.1 | 0.7 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.1 | 0.3 | GO:0060170 | ciliary membrane(GO:0060170) |
0.1 | 8.1 | GO:0005769 | early endosome(GO:0005769) |
0.1 | 1.1 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.1 | 2.1 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.1 | 0.9 | GO:0033391 | chromatoid body(GO:0033391) |
0.1 | 6.6 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.1 | 12.3 | GO:0044456 | synapse part(GO:0044456) |
0.1 | 1.1 | GO:0031304 | intrinsic component of mitochondrial inner membrane(GO:0031304) |
0.1 | 6.0 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.1 | 2.8 | GO:0016592 | mediator complex(GO:0016592) |
0.1 | 4.2 | GO:0016605 | PML body(GO:0016605) |
0.1 | 0.7 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.1 | 0.2 | GO:0005657 | replication fork(GO:0005657) |
0.1 | 0.4 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.1 | 0.4 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.1 | 0.1 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.1 | 4.0 | GO:0031514 | motile cilium(GO:0031514) |
0.1 | 0.2 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.1 | 2.5 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.1 | 1.1 | GO:0005839 | proteasome core complex(GO:0005839) |
0.1 | 0.3 | GO:0045251 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.1 | 0.1 | GO:0016234 | inclusion body(GO:0016234) |
0.1 | 2.1 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
0.1 | 0.2 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.1 | 144.3 | GO:0005576 | extracellular region(GO:0005576) |
0.1 | 0.3 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.1 | 3.3 | GO:0000139 | Golgi membrane(GO:0000139) |
0.1 | 0.2 | GO:0097342 | ripoptosome(GO:0097342) |
0.1 | 1.9 | GO:0048471 | perinuclear region of cytoplasm(GO:0048471) |
0.1 | 0.2 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) TAP complex(GO:0042825) |
0.1 | 0.2 | GO:0035859 | Seh1-associated complex(GO:0035859) Iml1 complex(GO:1990130) |
0.1 | 21.3 | GO:0005794 | Golgi apparatus(GO:0005794) |
0.1 | 0.1 | GO:0042588 | zymogen granule(GO:0042588) |
0.1 | 0.1 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.1 | 0.1 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.1 | 0.3 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.1 | 0.1 | GO:0098802 | plasma membrane receptor complex(GO:0098802) |
0.1 | 3.0 | GO:0043005 | neuron projection(GO:0043005) |
0.1 | 0.8 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.1 | 4.9 | GO:0009986 | cell surface(GO:0009986) |
0.1 | 0.2 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.1 | 0.3 | GO:0044437 | vacuolar part(GO:0044437) |
0.1 | 0.4 | GO:0035267 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.1 | 0.1 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.1 | 0.2 | GO:0055087 | Ski complex(GO:0055087) |
0.1 | 78.8 | GO:0031224 | intrinsic component of membrane(GO:0031224) |
0.1 | 0.2 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.1 | 0.1 | GO:0036396 | MIS complex(GO:0036396) mRNA editing complex(GO:0045293) |
0.1 | 169.7 | GO:0005634 | nucleus(GO:0005634) |
0.1 | 0.5 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.1 | 1.8 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 20.4 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.0 | 0.0 | GO:0097546 | ciliary base(GO:0097546) |
0.0 | 2.2 | GO:0016020 | membrane(GO:0016020) |
0.0 | 59.9 | GO:0044464 | cell part(GO:0044464) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
14.1 | 42.4 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
9.0 | 27.1 | GO:0031014 | troponin T binding(GO:0031014) |
9.0 | 26.9 | GO:0030172 | troponin C binding(GO:0030172) |
8.7 | 26.0 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
8.5 | 25.5 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
7.5 | 60.1 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
7.4 | 44.5 | GO:0030274 | LIM domain binding(GO:0030274) |
7.3 | 21.8 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
6.4 | 25.7 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
6.2 | 30.9 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
6.2 | 18.5 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
5.9 | 35.7 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
5.3 | 26.7 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
5.2 | 15.5 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
4.7 | 47.3 | GO:0017166 | vinculin binding(GO:0017166) |
4.7 | 18.7 | GO:0051434 | BH3 domain binding(GO:0051434) |
4.3 | 13.0 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
4.2 | 12.6 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
3.7 | 44.8 | GO:0044548 | S100 protein binding(GO:0044548) |
3.6 | 7.2 | GO:0031013 | troponin I binding(GO:0031013) |
3.4 | 3.4 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
3.4 | 24.0 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
3.3 | 73.0 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
3.3 | 35.9 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
3.2 | 9.7 | GO:0015315 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
3.2 | 9.5 | GO:0004082 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
3.1 | 6.3 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
3.1 | 31.2 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
3.1 | 12.4 | GO:0042731 | PH domain binding(GO:0042731) |
3.1 | 9.3 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
3.0 | 48.6 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
3.0 | 17.8 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
3.0 | 35.6 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
3.0 | 32.5 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
2.9 | 8.8 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
2.9 | 20.2 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
2.9 | 17.3 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
2.9 | 8.6 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
2.9 | 8.6 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
2.8 | 16.5 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
2.7 | 35.5 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
2.7 | 16.1 | GO:0043495 | protein anchor(GO:0043495) |
2.7 | 8.0 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
2.6 | 20.9 | GO:0005523 | tropomyosin binding(GO:0005523) |
2.6 | 10.4 | GO:0015057 | thrombin receptor activity(GO:0015057) |
2.5 | 7.5 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
2.5 | 15.0 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
2.5 | 7.5 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
2.5 | 10.0 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
2.5 | 10.0 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
2.5 | 4.9 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
2.5 | 29.5 | GO:0035497 | cAMP response element binding(GO:0035497) |
2.5 | 7.4 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
2.4 | 4.8 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
2.4 | 14.5 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
2.4 | 26.4 | GO:0045294 | alpha-catenin binding(GO:0045294) |
2.4 | 4.8 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
2.4 | 9.6 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
2.4 | 12.0 | GO:0035671 | enone reductase activity(GO:0035671) |
2.4 | 14.3 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
2.4 | 2.4 | GO:0070052 | collagen V binding(GO:0070052) |
2.4 | 9.5 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
2.4 | 11.9 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
2.3 | 23.5 | GO:0031996 | thioesterase binding(GO:0031996) |
2.3 | 9.4 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
2.3 | 9.3 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) |
2.3 | 6.9 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
2.3 | 9.2 | GO:0005042 | netrin receptor activity(GO:0005042) |
2.2 | 6.7 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
2.2 | 2.2 | GO:0070538 | oleic acid binding(GO:0070538) |
2.2 | 6.5 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
2.1 | 4.3 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
2.1 | 8.5 | GO:0004488 | methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
2.1 | 36.0 | GO:0070064 | proline-rich region binding(GO:0070064) |
2.1 | 18.8 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
2.1 | 2.1 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
2.1 | 14.4 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
2.0 | 8.2 | GO:0038064 | collagen receptor activity(GO:0038064) |
2.0 | 18.4 | GO:0038191 | neuropilin binding(GO:0038191) |
2.0 | 10.2 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
2.0 | 30.2 | GO:0017049 | GTP-Rho binding(GO:0017049) |
2.0 | 29.9 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
1.9 | 31.1 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
1.9 | 7.7 | GO:0015232 | heme transporter activity(GO:0015232) |
1.9 | 5.8 | GO:0048030 | disaccharide binding(GO:0048030) |
1.9 | 38.1 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
1.9 | 70.3 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
1.9 | 3.8 | GO:0004849 | uridine kinase activity(GO:0004849) |
1.9 | 5.6 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
1.9 | 1.9 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) |
1.8 | 7.4 | GO:0070191 | methionine-R-sulfoxide reductase activity(GO:0070191) |
1.8 | 3.7 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
1.8 | 7.2 | GO:0043842 | Kdo transferase activity(GO:0043842) |
1.8 | 5.4 | GO:0038181 | bile acid receptor activity(GO:0038181) |
1.8 | 16.1 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
1.8 | 10.7 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
1.8 | 12.4 | GO:0018471 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
1.8 | 3.5 | GO:0051373 | FATZ binding(GO:0051373) |
1.7 | 5.2 | GO:0004470 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
1.7 | 8.5 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
1.7 | 11.9 | GO:0031432 | titin binding(GO:0031432) |
1.7 | 1.7 | GO:0000009 | alpha-1,6-mannosyltransferase activity(GO:0000009) |
1.7 | 16.8 | GO:0070700 | BMP receptor binding(GO:0070700) |
1.7 | 5.0 | GO:0019959 | interleukin-8 binding(GO:0019959) |
1.7 | 1.7 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
1.7 | 5.0 | GO:0005534 | galactose binding(GO:0005534) |
1.6 | 6.6 | GO:1990715 | mRNA CDS binding(GO:1990715) |
1.6 | 31.1 | GO:0030552 | cAMP binding(GO:0030552) |
1.6 | 3.3 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
1.6 | 14.6 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
1.6 | 6.5 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
1.6 | 85.6 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
1.6 | 6.4 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
1.6 | 15.9 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
1.6 | 7.9 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
1.6 | 17.3 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
1.6 | 9.4 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
1.6 | 4.7 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
1.6 | 4.7 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
1.6 | 1.6 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
1.6 | 6.2 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
1.5 | 6.1 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
1.5 | 7.6 | GO:0002162 | dystroglycan binding(GO:0002162) |
1.5 | 6.1 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
1.5 | 7.6 | GO:0016936 | galactoside binding(GO:0016936) |
1.5 | 6.0 | GO:0071253 | connexin binding(GO:0071253) |
1.5 | 7.5 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
1.5 | 20.9 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
1.5 | 3.0 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
1.5 | 7.5 | GO:0045502 | dynein binding(GO:0045502) |
1.5 | 4.4 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
1.5 | 4.4 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
1.5 | 19.1 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
1.5 | 5.9 | GO:0008865 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
1.5 | 7.3 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
1.5 | 33.6 | GO:0043236 | laminin binding(GO:0043236) |
1.4 | 18.8 | GO:0034185 | apolipoprotein binding(GO:0034185) |
1.4 | 8.7 | GO:0070324 | thyroid hormone binding(GO:0070324) |
1.4 | 14.3 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
1.4 | 1.4 | GO:0070728 | leucine binding(GO:0070728) |
1.4 | 4.3 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
1.4 | 5.6 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
1.4 | 24.0 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
1.4 | 7.0 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
1.4 | 34.9 | GO:0046875 | ephrin receptor binding(GO:0046875) |
1.4 | 4.2 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
1.4 | 5.6 | GO:0005047 | signal recognition particle binding(GO:0005047) |
1.4 | 7.0 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
1.4 | 2.8 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
1.4 | 120.9 | GO:0051015 | actin filament binding(GO:0051015) |
1.4 | 11.1 | GO:0004622 | lysophospholipase activity(GO:0004622) |
1.4 | 6.9 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
1.4 | 1.4 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
1.4 | 5.5 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
1.4 | 4.1 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
1.3 | 6.6 | GO:0070883 | pre-miRNA binding(GO:0070883) |
1.3 | 2.6 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
1.3 | 9.2 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
1.3 | 3.8 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
1.3 | 3.8 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
1.2 | 7.5 | GO:0005536 | glucose binding(GO:0005536) |
1.2 | 19.8 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
1.2 | 141.6 | GO:0008201 | heparin binding(GO:0008201) |
1.2 | 4.9 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
1.2 | 18.2 | GO:0008143 | poly(A) binding(GO:0008143) |
1.2 | 4.8 | GO:0018741 | alkyl sulfatase activity(GO:0018741) endosulfan hemisulfate sulfatase activity(GO:0034889) endosulfan sulfate hydrolase activity(GO:0034902) |
1.2 | 3.6 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
1.2 | 3.6 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
1.2 | 10.9 | GO:0005003 | ephrin receptor activity(GO:0005003) |
1.2 | 13.3 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
1.2 | 3.6 | GO:0008142 | oxysterol binding(GO:0008142) |
1.2 | 3.6 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
1.2 | 17.9 | GO:0042805 | actinin binding(GO:0042805) |
1.2 | 250.7 | GO:0003779 | actin binding(GO:0003779) |
1.2 | 20.3 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
1.2 | 4.8 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
1.2 | 11.9 | GO:0016918 | retinal binding(GO:0016918) |
1.2 | 5.9 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
1.2 | 2.4 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
1.2 | 8.2 | GO:0035198 | miRNA binding(GO:0035198) |
1.2 | 4.6 | GO:0048185 | activin binding(GO:0048185) |
1.1 | 47.1 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
1.1 | 3.4 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
1.1 | 4.6 | GO:1904288 | BAT3 complex binding(GO:1904288) |
1.1 | 10.2 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
1.1 | 5.7 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
1.1 | 3.4 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
1.1 | 4.5 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
1.1 | 2.3 | GO:0004771 | sterol esterase activity(GO:0004771) |
1.1 | 20.3 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
1.1 | 3.4 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
1.1 | 3.4 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
1.1 | 1.1 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
1.1 | 3.3 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
1.1 | 67.5 | GO:0005178 | integrin binding(GO:0005178) |
1.1 | 6.6 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
1.1 | 4.4 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
1.1 | 4.4 | GO:0008430 | selenium binding(GO:0008430) |
1.1 | 3.3 | GO:0098821 | BMP receptor activity(GO:0098821) |
1.1 | 3.3 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
1.1 | 3.3 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
1.1 | 1.1 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
1.1 | 4.3 | GO:0009374 | biotin binding(GO:0009374) |
1.1 | 3.2 | GO:0045182 | translation regulator activity(GO:0045182) |
1.1 | 6.3 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
1.1 | 4.2 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
1.0 | 5.2 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
1.0 | 2.1 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
1.0 | 25.2 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
1.0 | 3.1 | GO:0070411 | I-SMAD binding(GO:0070411) |
1.0 | 5.2 | GO:0004111 | creatine kinase activity(GO:0004111) |
1.0 | 3.1 | GO:0005345 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
1.0 | 3.1 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
1.0 | 3.1 | GO:0089720 | caspase binding(GO:0089720) |
1.0 | 11.3 | GO:0005451 | monovalent cation:proton antiporter activity(GO:0005451) |
1.0 | 13.3 | GO:0030371 | translation repressor activity(GO:0030371) |
1.0 | 5.1 | GO:0051525 | NFAT protein binding(GO:0051525) |
1.0 | 19.3 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
1.0 | 3.0 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
1.0 | 6.1 | GO:0019966 | interleukin-1 binding(GO:0019966) |
1.0 | 3.0 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
1.0 | 27.2 | GO:0017147 | Wnt-protein binding(GO:0017147) |
1.0 | 13.1 | GO:0050840 | extracellular matrix binding(GO:0050840) |
1.0 | 5.0 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
1.0 | 12.0 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
1.0 | 1.0 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
1.0 | 16.8 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
1.0 | 2.0 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
1.0 | 2.0 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
1.0 | 2.9 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
1.0 | 3.8 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
1.0 | 2.9 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.9 | 3.8 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.9 | 2.8 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.9 | 0.9 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.9 | 32.9 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
0.9 | 2.8 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.9 | 1.8 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.9 | 5.5 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.9 | 2.7 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.9 | 3.7 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.9 | 0.9 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.9 | 6.4 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.9 | 6.4 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.9 | 10.0 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.9 | 6.4 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.9 | 0.9 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.9 | 0.9 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
0.9 | 4.5 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.9 | 4.5 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.9 | 3.6 | GO:0034594 | phosphatidylinositol trisphosphate phosphatase activity(GO:0034594) |
0.9 | 3.6 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.9 | 4.5 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.9 | 9.8 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.9 | 2.7 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.9 | 4.4 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.9 | 4.4 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
0.9 | 7.9 | GO:0046972 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.9 | 2.6 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.9 | 2.6 | GO:0030911 | TPR domain binding(GO:0030911) |
0.9 | 2.6 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.9 | 0.9 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.9 | 1.7 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
0.9 | 1.7 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.9 | 4.3 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.9 | 2.6 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.8 | 2.5 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.8 | 3.4 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.8 | 0.8 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
0.8 | 5.9 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.8 | 3.4 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.8 | 2.5 | GO:0035939 | microsatellite binding(GO:0035939) |
0.8 | 0.8 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.8 | 0.8 | GO:0043426 | MRF binding(GO:0043426) |
0.8 | 3.3 | GO:0035197 | siRNA binding(GO:0035197) |
0.8 | 3.3 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.8 | 1.7 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.8 | 3.3 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.8 | 2.5 | GO:0015265 | urea channel activity(GO:0015265) |
0.8 | 7.4 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.8 | 3.3 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.8 | 8.1 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.8 | 0.8 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.8 | 20.2 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.8 | 2.4 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.8 | 7.2 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.8 | 2.4 | GO:0016668 | oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor(GO:0016668) |
0.8 | 0.8 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.8 | 2.4 | GO:0036033 | mediator complex binding(GO:0036033) |
0.8 | 4.0 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.8 | 2.4 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.8 | 0.8 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.8 | 10.2 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.8 | 1.6 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
0.8 | 3.9 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.8 | 2.3 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.8 | 1.6 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.8 | 1.5 | GO:0000339 | RNA cap binding(GO:0000339) |
0.8 | 0.8 | GO:0043139 | 5'-3' DNA helicase activity(GO:0043139) |
0.8 | 4.6 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.8 | 3.1 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.8 | 7.6 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.8 | 0.8 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.8 | 4.5 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.8 | 2.3 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.8 | 3.0 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.8 | 9.0 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.8 | 9.8 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.7 | 2.2 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.7 | 5.9 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
0.7 | 5.9 | GO:0016662 | oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor(GO:0016662) |
0.7 | 2.2 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.7 | 1.5 | GO:0015556 | L-aspartate transmembrane transporter activity(GO:0015183) C4-dicarboxylate transmembrane transporter activity(GO:0015556) |
0.7 | 4.4 | GO:0005057 | receptor signaling protein activity(GO:0005057) |
0.7 | 16.8 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.7 | 1.5 | GO:0070840 | dynein complex binding(GO:0070840) |
0.7 | 2.9 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.7 | 2.2 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.7 | 12.3 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.7 | 1.4 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.7 | 1.4 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.7 | 3.6 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.7 | 1.4 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.7 | 2.1 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.7 | 1.4 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.7 | 6.4 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.7 | 1.4 | GO:0038100 | nodal binding(GO:0038100) |
0.7 | 25.5 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.7 | 3.5 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.7 | 19.0 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
0.7 | 3.5 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.7 | 2.1 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.7 | 2.1 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.7 | 9.8 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
0.7 | 9.0 | GO:0017022 | myosin binding(GO:0017022) |
0.7 | 11.0 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.7 | 6.9 | GO:0004954 | prostanoid receptor activity(GO:0004954) |
0.7 | 1.4 | GO:0051430 | corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
0.7 | 3.4 | GO:0030546 | receptor activator activity(GO:0030546) |
0.7 | 8.8 | GO:0030955 | potassium ion binding(GO:0030955) |
0.7 | 2.0 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.7 | 4.7 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.7 | 6.1 | GO:0030275 | LRR domain binding(GO:0030275) |
0.7 | 2.7 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.7 | 1.3 | GO:0016419 | S-malonyltransferase activity(GO:0016419) malonyltransferase activity(GO:0016420) |
0.7 | 6.0 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.7 | 2.6 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.7 | 11.2 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.7 | 1.3 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) cardiolipin binding(GO:1901612) |
0.7 | 1.3 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.7 | 7.3 | GO:0005123 | death receptor binding(GO:0005123) |
0.7 | 2.0 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.7 | 2.6 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
0.7 | 3.9 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.7 | 2.0 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.7 | 3.3 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.7 | 10.4 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.7 | 2.0 | GO:0070513 | death domain binding(GO:0070513) |
0.6 | 3.2 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.6 | 1.9 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.6 | 1.9 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.6 | 4.5 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.6 | 1.3 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.6 | 1.9 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.6 | 3.8 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.6 | 5.7 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.6 | 2.5 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.6 | 2.5 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.6 | 1.3 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.6 | 0.6 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.6 | 1.2 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.6 | 2.5 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.6 | 1.2 | GO:0070851 | growth factor receptor binding(GO:0070851) |
0.6 | 1.2 | GO:1990254 | keratin filament binding(GO:1990254) |
0.6 | 4.3 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.6 | 1.8 | GO:0004103 | choline kinase activity(GO:0004103) |
0.6 | 52.6 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.6 | 1.8 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.6 | 10.3 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.6 | 3.0 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.6 | 1.2 | GO:0004096 | catalase activity(GO:0004096) |
0.6 | 12.6 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.6 | 5.4 | GO:0005521 | lamin binding(GO:0005521) |
0.6 | 4.2 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.6 | 5.4 | GO:0004568 | chitinase activity(GO:0004568) |
0.6 | 1.2 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.6 | 0.6 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.6 | 0.6 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.6 | 10.6 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.6 | 62.5 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.6 | 4.1 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.6 | 3.5 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.6 | 1.2 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.6 | 5.8 | GO:0043274 | phospholipase binding(GO:0043274) |
0.6 | 1.2 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.6 | 2.3 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.6 | 10.3 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.6 | 4.0 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.6 | 179.3 | GO:0000982 | transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0000982) |
0.6 | 1.1 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.6 | 1.7 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.6 | 2.8 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.6 | 5.7 | GO:0048038 | quinone binding(GO:0048038) |
0.6 | 11.9 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.6 | 7.4 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.6 | 0.6 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.6 | 9.1 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.6 | 2.3 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.6 | 7.9 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
0.6 | 1.1 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.6 | 16.2 | GO:0008009 | chemokine activity(GO:0008009) |
0.6 | 3.9 | GO:0070403 | NAD+ binding(GO:0070403) |
0.6 | 1.1 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.6 | 1.7 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.6 | 0.6 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.6 | 1.1 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.6 | 2.2 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.6 | 7.7 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.5 | 7.7 | GO:0019894 | kinesin binding(GO:0019894) |
0.5 | 1.6 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.5 | 1.6 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.5 | 1.1 | GO:0015180 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
0.5 | 1.6 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.5 | 2.2 | GO:0035257 | nuclear hormone receptor binding(GO:0035257) |
0.5 | 16.7 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.5 | 1.6 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.5 | 0.5 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.5 | 12.7 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.5 | 1.6 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.5 | 5.3 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.5 | 3.2 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.5 | 16.4 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.5 | 2.1 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.5 | 1.6 | GO:0055100 | adiponectin binding(GO:0055100) |
0.5 | 2.1 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.5 | 4.2 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.5 | 1.0 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.5 | 2.1 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.5 | 2.1 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.5 | 8.8 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.5 | 1.5 | GO:0045545 | syndecan binding(GO:0045545) |
0.5 | 11.2 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.5 | 7.1 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.5 | 6.0 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.5 | 1.0 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.5 | 3.0 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.5 | 3.5 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.5 | 2.0 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.5 | 84.0 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.5 | 1.5 | GO:0008732 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.5 | 4.9 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.5 | 0.5 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.5 | 16.4 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.5 | 4.8 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.5 | 2.4 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.5 | 0.5 | GO:0015278 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.5 | 4.3 | GO:0016215 | acyl-CoA desaturase activity(GO:0016215) |
0.5 | 0.5 | GO:0051425 | PTB domain binding(GO:0051425) |
0.5 | 5.2 | GO:0055106 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
0.5 | 2.8 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.5 | 0.9 | GO:0032190 | acrosin binding(GO:0032190) |
0.5 | 3.8 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.5 | 2.3 | GO:0050543 | icosatetraenoic acid binding(GO:0050543) |
0.5 | 0.5 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.5 | 7.9 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.5 | 8.9 | GO:0005539 | glycosaminoglycan binding(GO:0005539) |
0.5 | 0.9 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.5 | 0.5 | GO:0031433 | telethonin binding(GO:0031433) |
0.5 | 0.5 | GO:0015226 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.5 | 1.4 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.5 | 1.8 | GO:0016775 | phosphotransferase activity, nitrogenous group as acceptor(GO:0016775) |
0.5 | 1.8 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.5 | 0.5 | GO:0019862 | IgA binding(GO:0019862) |
0.5 | 2.3 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.5 | 3.7 | GO:0044466 | 2-oxoglutaryl-CoA thioesterase activity(GO:0034843) 2,4,4-trimethyl-3-oxopentanoyl-CoA thioesterase activity(GO:0034869) 3-isopropylbut-3-enoyl-CoA thioesterase activity(GO:0034946) glutaryl-CoA hydrolase activity(GO:0044466) |
0.5 | 1.8 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.5 | 10.0 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.5 | 15.0 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.5 | 2.7 | GO:0015288 | porin activity(GO:0015288) |
0.4 | 1.3 | GO:0036122 | BMP binding(GO:0036122) |
0.4 | 3.6 | GO:0018446 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.4 | 1.8 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.4 | 17.5 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.4 | 10.9 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.4 | 26.0 | GO:0031072 | heat shock protein binding(GO:0031072) |
0.4 | 2.2 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.4 | 0.9 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.4 | 3.0 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.4 | 1.7 | GO:0052717 | N-cyclopropylmelamine deaminase activity(GO:0034547) N-cyclopropylammeline deaminase activity(GO:0034548) N-cyclopropylammelide alkylamino hydrolase activity(GO:0034549) 2,5-diamino-6-ribitylamino-4(3H)-pyrimidinone 5'-phosphate deaminase activity(GO:0043723) tRNA-specific adenosine-37 deaminase activity(GO:0043829) archaeal-specific GTP cyclohydrolase activity(GO:0044682) tRNA-specific adenosine-34 deaminase activity(GO:0052717) |
0.4 | 2.5 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.4 | 1.3 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.4 | 7.2 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.4 | 1.3 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.4 | 0.8 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.4 | 1.7 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.4 | 2.1 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.4 | 10.0 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.4 | 0.8 | GO:0015101 | organic cation transmembrane transporter activity(GO:0015101) |
0.4 | 4.1 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.4 | 2.5 | GO:0019203 | carbohydrate phosphatase activity(GO:0019203) sugar-phosphatase activity(GO:0050308) |
0.4 | 0.4 | GO:0008251 | tRNA-specific adenosine deaminase activity(GO:0008251) |
0.4 | 1.6 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.4 | 1.6 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.4 | 3.6 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.4 | 3.2 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.4 | 1.2 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.4 | 0.8 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.4 | 4.7 | GO:0097110 | scaffold protein binding(GO:0097110) |
0.4 | 3.6 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.4 | 3.5 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.4 | 6.3 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.4 | 2.3 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.4 | 0.8 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.4 | 0.4 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.4 | 8.4 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.4 | 11.8 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.4 | 0.4 | GO:0034452 | dynactin binding(GO:0034452) |
0.4 | 6.8 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.4 | 3.0 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.4 | 3.4 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.4 | 1.1 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.4 | 1.1 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.4 | 0.7 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
0.4 | 1.1 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.4 | 1.1 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.4 | 97.4 | GO:0005525 | GTP binding(GO:0005525) |
0.4 | 0.7 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.4 | 2.2 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.4 | 1.5 | GO:0036137 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.4 | 19.8 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.4 | 1.1 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.4 | 6.0 | GO:0019239 | deaminase activity(GO:0019239) |
0.4 | 1.1 | GO:0050694 | galactose 3-O-sulfotransferase activity(GO:0050694) |
0.4 | 2.1 | GO:0015464 | acetylcholine receptor activity(GO:0015464) |
0.4 | 4.9 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.4 | 3.9 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.3 | 1.0 | GO:0001846 | opsonin binding(GO:0001846) |
0.3 | 12.2 | GO:0002039 | p53 binding(GO:0002039) |
0.3 | 2.4 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.3 | 1.4 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.3 | 0.3 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.3 | 1.0 | GO:0048156 | tau protein binding(GO:0048156) |
0.3 | 1.0 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.3 | 0.7 | GO:0034584 | piRNA binding(GO:0034584) |
0.3 | 1.0 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.3 | 1.4 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.3 | 1.7 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.3 | 2.0 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.3 | 1.0 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.3 | 0.3 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.3 | 1.7 | GO:0050700 | CARD domain binding(GO:0050700) |
0.3 | 0.7 | GO:0018585 | fluorene oxygenase activity(GO:0018585) |
0.3 | 3.6 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.3 | 2.0 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.3 | 0.7 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.3 | 1.3 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.3 | 1.0 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.3 | 3.6 | GO:0016645 | oxidoreductase activity, acting on the CH-NH group of donors(GO:0016645) |
0.3 | 1.0 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.3 | 1.6 | GO:0050733 | RS domain binding(GO:0050733) |
0.3 | 1.9 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.3 | 0.3 | GO:0019187 | beta-1,4-mannosyltransferase activity(GO:0019187) |
0.3 | 0.6 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.3 | 1.3 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.3 | 0.3 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.3 | 2.5 | GO:0031005 | filamin binding(GO:0031005) |
0.3 | 0.3 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
0.3 | 4.6 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.3 | 1.5 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.3 | 3.3 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.3 | 1.8 | GO:0098988 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) G-protein coupled glutamate receptor activity(GO:0098988) |
0.3 | 2.4 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.3 | 16.2 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.3 | 4.1 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.3 | 0.6 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.3 | 0.3 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.3 | 20.5 | GO:0005179 | hormone activity(GO:0005179) |
0.3 | 0.3 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.3 | 0.9 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.3 | 0.9 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.3 | 2.6 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.3 | 0.6 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.3 | 15.1 | GO:0042393 | histone binding(GO:0042393) |
0.3 | 2.8 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.3 | 0.3 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.3 | 1.4 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.3 | 1.1 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.3 | 26.5 | GO:0005125 | cytokine activity(GO:0005125) |
0.3 | 0.3 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.3 | 0.5 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.3 | 1.3 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.3 | 1.3 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.3 | 1.3 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.3 | 8.8 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.3 | 2.7 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.3 | 0.3 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.3 | 2.4 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.3 | 2.1 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
0.3 | 2.9 | GO:0022841 | leak channel activity(GO:0022840) potassium ion leak channel activity(GO:0022841) narrow pore channel activity(GO:0022842) |
0.3 | 0.8 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.3 | 9.1 | GO:0030674 | protein binding, bridging(GO:0030674) binding, bridging(GO:0060090) |
0.3 | 1.3 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.3 | 1.0 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.2 | 0.7 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.2 | 0.2 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
0.2 | 4.9 | GO:0019903 | protein phosphatase binding(GO:0019903) |
0.2 | 1.7 | GO:0070888 | E-box binding(GO:0070888) |
0.2 | 2.4 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.2 | 0.5 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.2 | 0.2 | GO:2001070 | starch binding(GO:2001070) |
0.2 | 0.7 | GO:0008066 | glutamate receptor activity(GO:0008066) |
0.2 | 0.7 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.2 | 0.7 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.2 | 1.2 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.2 | 0.5 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.2 | 2.1 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.2 | 0.5 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.2 | 2.8 | GO:0005272 | sodium channel activity(GO:0005272) |
0.2 | 0.7 | GO:0015197 | peptide transporter activity(GO:0015197) |
0.2 | 4.3 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.2 | 0.7 | GO:0090079 | translation regulator activity, nucleic acid binding(GO:0090079) |
0.2 | 0.9 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.2 | 0.2 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.2 | 0.4 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.2 | 0.7 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.2 | 1.5 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.2 | 1.3 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.2 | 3.3 | GO:0005518 | collagen binding(GO:0005518) |
0.2 | 7.8 | GO:0004027 | alcohol sulfotransferase activity(GO:0004027) |
0.2 | 2.8 | GO:0030332 | cyclin binding(GO:0030332) |
0.2 | 4.3 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.2 | 0.4 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.2 | 17.4 | GO:0008017 | microtubule binding(GO:0008017) |
0.2 | 0.6 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.2 | 0.2 | GO:0055102 | lipase inhibitor activity(GO:0055102) |
0.2 | 0.6 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.2 | 0.2 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.2 | 1.5 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.2 | 0.2 | GO:0001099 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
0.2 | 1.2 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.2 | 2.1 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.2 | 0.2 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.2 | 0.4 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.2 | 0.4 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.2 | 0.8 | GO:0016885 | ligase activity, forming carbon-carbon bonds(GO:0016885) |
0.2 | 0.2 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.2 | 0.4 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.2 | 11.4 | GO:0000149 | SNARE binding(GO:0000149) |
0.2 | 0.4 | GO:0030519 | snoRNP binding(GO:0030519) |
0.2 | 1.2 | GO:0015605 | organophosphate ester transmembrane transporter activity(GO:0015605) |
0.2 | 1.6 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.2 | 3.1 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.2 | 16.4 | GO:0008134 | transcription factor binding(GO:0008134) |
0.2 | 2.9 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.2 | 0.2 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.2 | 0.4 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.2 | 0.4 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.2 | 5.5 | GO:0051723 | protein methylesterase activity(GO:0051723) |
0.2 | 0.6 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.2 | 9.9 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.2 | 15.2 | GO:0003729 | mRNA binding(GO:0003729) |
0.2 | 1.3 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.2 | 8.0 | GO:0004721 | phosphoprotein phosphatase activity(GO:0004721) |
0.2 | 0.4 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.2 | 0.9 | GO:0003909 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.2 | 0.6 | GO:0035473 | lipase binding(GO:0035473) |
0.2 | 0.7 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.2 | 0.2 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.2 | 0.5 | GO:0034811 | 2,3-dihydroxy DDT 1,2-dioxygenase activity(GO:0018542) phenanthrene dioxygenase activity(GO:0018555) 2,2',3-trihydroxybiphenyl dioxygenase activity(GO:0018556) 1,2-dihydroxyfluorene 1,1-alpha-dioxygenase activity(GO:0018557) 5,6-dihydroxy-3-methyl-2-oxo-1,2-dihydroquinoline dioxygenase activity(GO:0018558) 1,1-dichloro-2-(dihydroxy-4-chlorophenyl)-(4-chlorophenyl)ethene 1,2-dioxygenase activity(GO:0018559) protocatechuate 3,4-dioxygenase type II activity(GO:0018560) 2'-aminobiphenyl-2,3-diol 1,2-dioxygenase activity(GO:0018561) 3,4-dihydroxyfluorene 4,4-alpha-dioxygenase activity(GO:0018562) 2,3-dihydroxy-ethylbenzene 1,2-dioxygenase activity(GO:0018563) carbazole 1,9a-dioxygenase activity(GO:0018564) dihydroxydibenzothiophene dioxygenase activity(GO:0018565) 1,2-dihydroxynaphthalene-6-sulfonate 1,8a-dioxygenase activity(GO:0018566) styrene dioxygenase activity(GO:0018567) 3,4-dihydroxyphenanthrene dioxygenase activity(GO:0018568) hydroquinone 1,2-dioxygenase activity(GO:0018569) p-cumate 2,3-dioxygenase activity(GO:0018570) 2,3-dihydroxy-p-cumate dioxygenase activity(GO:0018571) 3,5-dichlorocatechol 1,2-dioxygenase activity(GO:0018572) 2-aminophenol 1,6-dioxygenase activity(GO:0018573) 2,6-dichloro-p-hydroquinone 1,2-dioxygenase activity(GO:0018574) chlorocatechol 1,2-dioxygenase activity(GO:0018575) catechol dioxygenase activity(GO:0019114) dihydroxyfluorene dioxygenase activity(GO:0019117) 5-aminosalicylate dioxygenase activity(GO:0034543) 3-hydroxy-2-naphthoate 2,3-dioxygenase activity(GO:0034803) benzo(a)pyrene 11,12-dioxygenase activity(GO:0034806) benzo(a)pyrene 4,5-dioxygenase activity(GO:0034808) 4,5-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034810) benzo(a)pyrene 9,10-dioxygenase activity(GO:0034811) 9,10-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034812) benzo(a)pyrene 7,8-dioxygenase activity(GO:0034813) 7,8-dihydroxy benzo(a)pyrene dioxygenase activity(GO:0034814) 1,2-dihydroxy-5,6,7,8-tetrahydronaphthalene extradiol dioxygenase activity(GO:0034827) 2-mercaptobenzothiazole dioxygenase activity(GO:0034834) pyridine-3,4-diol dioxygenase activity(GO:0034895) pyrene dioxygenase activity(GO:0034920) 4,5-dihydroxypyrene dioxygenase activity(GO:0034922) phenanthrene-4-carboxylate dioxygenase activity(GO:0034934) tetrachlorobenzene dioxygenase activity(GO:0034935) 4,6-dichloro-3-methylcatechol 1,2-dioxygenase activity(GO:0034936) 2,3-dihydroxydiphenyl ether dioxygenase activity(GO:0034955) diphenyl ether 1,2-dioxygenase activity(GO:0034956) arachidonate 8(S)-lipoxygenase activity(GO:0036403) 4-hydroxycatechol 1,2-dioxygenase activity(GO:0047074) |
0.2 | 3.1 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.2 | 0.4 | GO:0034618 | arginine binding(GO:0034618) |
0.2 | 1.4 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.2 | 0.9 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.2 | 0.4 | GO:0047105 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
0.2 | 2.7 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.2 | 4.2 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.2 | 0.4 | GO:0033265 | choline binding(GO:0033265) |
0.2 | 0.3 | GO:0016803 | ether hydrolase activity(GO:0016803) |
0.2 | 0.3 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.2 | 0.7 | GO:0015922 | aspartate oxidase activity(GO:0015922) |
0.2 | 7.3 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
0.2 | 0.7 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.2 | 4.0 | GO:0032934 | sterol binding(GO:0032934) |
0.2 | 0.2 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.2 | 1.5 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.2 | 0.5 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.2 | 50.5 | GO:0005509 | calcium ion binding(GO:0005509) |
0.2 | 0.3 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.2 | 1.9 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.2 | 0.2 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.2 | 0.2 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.2 | 0.2 | GO:0002134 | UTP binding(GO:0002134) pyrimidine ribonucleoside binding(GO:0032551) |
0.2 | 3.2 | GO:0033765 | steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) |
0.2 | 0.2 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
0.2 | 0.3 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.2 | 0.5 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.2 | 0.2 | GO:0031701 | angiotensin receptor binding(GO:0031701) |
0.2 | 0.6 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.2 | 2.6 | GO:0005109 | frizzled binding(GO:0005109) |
0.1 | 1.0 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.1 | 1.5 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) |
0.1 | 0.4 | GO:0002046 | opsin binding(GO:0002046) |
0.1 | 0.3 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.1 | 0.9 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
0.1 | 1.0 | GO:0031491 | nucleosome binding(GO:0031491) |
0.1 | 1.3 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.1 | 0.1 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.1 | 0.4 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.1 | 1.0 | GO:0045296 | cadherin binding(GO:0045296) |
0.1 | 0.3 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.1 | 0.1 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.1 | 0.1 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
0.1 | 0.9 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.1 | 0.4 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.1 | 1.3 | GO:0004879 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
0.1 | 0.8 | GO:0051400 | BH domain binding(GO:0051400) |
0.1 | 16.8 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.1 | 0.1 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.1 | 0.4 | GO:0046978 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.1 | 1.0 | GO:0046977 | TAP binding(GO:0046977) |
0.1 | 0.4 | GO:0070402 | NADPH binding(GO:0070402) |
0.1 | 1.0 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.1 | 5.2 | GO:0016410 | N-acyltransferase activity(GO:0016410) |
0.1 | 0.5 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.1 | 0.6 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.1 | 0.5 | GO:0039706 | co-receptor binding(GO:0039706) |
0.1 | 0.1 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.1 | 1.4 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.1 | 0.4 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.1 | 2.1 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 1.0 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.1 | 0.8 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.1 | 0.5 | GO:0034603 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.1 | 0.2 | GO:0016151 | nickel cation binding(GO:0016151) |
0.1 | 1.0 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.1 | 0.1 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
0.1 | 0.9 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.1 | 0.3 | GO:0035326 | enhancer binding(GO:0035326) |
0.1 | 1.1 | GO:0030276 | clathrin binding(GO:0030276) |
0.1 | 3.9 | GO:0008527 | taste receptor activity(GO:0008527) |
0.1 | 0.1 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.1 | 0.2 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.1 | 0.3 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.1 | 0.4 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.1 | 4.5 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.1 | 0.5 | GO:0050664 | oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor(GO:0050664) |
0.1 | 0.5 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) |
0.1 | 1.4 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.1 | 0.4 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.1 | 0.3 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.1 | 0.1 | GO:0042165 | neurotransmitter binding(GO:0042165) |
0.1 | 0.3 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
0.1 | 0.3 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.1 | 0.1 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.1 | 0.2 | GO:0019864 | IgG binding(GO:0019864) |
0.1 | 0.1 | GO:0008948 | oxaloacetate decarboxylase activity(GO:0008948) |
0.1 | 1.6 | GO:0004713 | protein tyrosine kinase activity(GO:0004713) |
0.1 | 0.2 | GO:0032052 | bile acid binding(GO:0032052) |
0.1 | 0.2 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.1 | 0.8 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.1 | 0.5 | GO:0019840 | isoprenoid binding(GO:0019840) |
0.1 | 0.1 | GO:0008061 | chitin binding(GO:0008061) |
0.1 | 0.1 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
0.1 | 0.1 | GO:0097016 | L27 domain binding(GO:0097016) |
0.1 | 0.1 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.1 | 2.0 | GO:0061650 | ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
0.1 | 0.7 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.1 | 0.4 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.1 | 0.6 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.1 | 0.1 | GO:0043199 | sulfate binding(GO:0043199) |
0.1 | 1.1 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.1 | 0.2 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.1 | 2.6 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.1 | 0.1 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.1 | 1.9 | GO:0005088 | Ras guanyl-nucleotide exchange factor activity(GO:0005088) |
0.1 | 22.3 | GO:0043565 | sequence-specific DNA binding(GO:0043565) |
0.1 | 14.9 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.1 | 0.4 | GO:0034875 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
0.1 | 2.1 | GO:0008391 | arachidonic acid monooxygenase activity(GO:0008391) |
0.1 | 5.9 | GO:0019901 | protein kinase binding(GO:0019901) |
0.1 | 1.8 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.1 | 0.1 | GO:0051734 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.1 | 0.1 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.0 | 0.0 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
0.0 | 0.1 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.0 | 0.1 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.0 | 0.1 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.0 | 0.7 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.0 | 0.5 | GO:0043621 | protein self-association(GO:0043621) |
0.0 | 0.1 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.0 | 0.2 | GO:0030295 | protein kinase activator activity(GO:0030295) |
0.0 | 0.2 | GO:0016937 | short-branched-chain-acyl-CoA dehydrogenase activity(GO:0016937) |
0.0 | 0.9 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.0 | 0.3 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 2.0 | GO:0008022 | protein C-terminus binding(GO:0008022) |
0.0 | 0.0 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.0 | 0.1 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.0 | 0.1 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.0 | 2.2 | GO:0015293 | symporter activity(GO:0015293) |
0.0 | 0.9 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
0.0 | 0.1 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
0.0 | 0.9 | GO:0008047 | enzyme activator activity(GO:0008047) |
0.0 | 0.2 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.0 | 0.1 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.0 | 0.3 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.0 | 0.0 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.0 | 0.7 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.0 | 0.3 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.0 | 0.0 | GO:0030228 | lipoprotein particle receptor activity(GO:0030228) |
0.0 | 0.1 | GO:0046790 | virion binding(GO:0046790) |
0.0 | 5.5 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
0.0 | 0.2 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.0 | 27.7 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 0.0 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.0 | 0.0 | GO:0032404 | mismatch repair complex binding(GO:0032404) |
0.0 | 0.0 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.0 | 0.1 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.0 | 0.1 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.0 | 0.1 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.0 | 0.7 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.0 | 0.1 | GO:0004556 | alpha-amylase activity(GO:0004556) |
0.0 | 0.1 | GO:0060589 | nucleoside-triphosphatase regulator activity(GO:0060589) |
0.0 | 0.1 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.0 | 0.0 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.0 | 0.0 | GO:0035870 | dITP diphosphatase activity(GO:0035870) XTP diphosphatase activity(GO:0036222) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.1 | 44.6 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
3.0 | 127.7 | NABA COLLAGENS | Genes encoding collagen proteins |
2.9 | 46.6 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
2.9 | 71.9 | PID NECTIN PATHWAY | Nectin adhesion pathway |
2.3 | 56.8 | PID IGF1 PATHWAY | IGF1 pathway |
2.2 | 39.2 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
2.2 | 75.8 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
2.1 | 2.1 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
2.0 | 50.0 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
2.0 | 2.0 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
1.9 | 65.9 | PID ILK PATHWAY | Integrin-linked kinase signaling |
1.9 | 17.2 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
1.9 | 43.6 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
1.8 | 17.6 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
1.7 | 5.0 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
1.6 | 66.8 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
1.4 | 30.2 | PID RAS PATHWAY | Regulation of Ras family activation |
1.4 | 17.2 | PID EPHB FWD PATHWAY | EPHB forward signaling |
1.4 | 44.1 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
1.3 | 37.3 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
1.2 | 9.7 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
1.2 | 10.9 | PID ALK2 PATHWAY | ALK2 signaling events |
1.2 | 13.1 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
1.2 | 14.3 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
1.2 | 43.5 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
1.2 | 185.4 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
1.1 | 39.9 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
1.1 | 60.0 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
1.1 | 5.7 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
1.1 | 31.6 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
1.1 | 9.0 | PID S1P S1P2 PATHWAY | S1P2 pathway |
1.1 | 11.0 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
1.1 | 30.3 | PID LKB1 PATHWAY | LKB1 signaling events |
1.1 | 7.5 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
1.1 | 20.4 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
1.1 | 4.3 | PID IL2 1PATHWAY | IL2-mediated signaling events |
1.1 | 8.5 | PID ALK1 PATHWAY | ALK1 signaling events |
1.0 | 3.1 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
1.0 | 13.5 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
1.0 | 33.8 | NABA CORE MATRISOME | Ensemble of genes encoding core extracellular matrix including ECM glycoproteins, collagens and proteoglycans |
1.0 | 3.0 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
1.0 | 18.1 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
1.0 | 15.1 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
1.0 | 5.9 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
1.0 | 15.8 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
1.0 | 13.6 | PID CD40 PATHWAY | CD40/CD40L signaling |
1.0 | 6.7 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.9 | 0.9 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.9 | 3.7 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.9 | 11.9 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.9 | 15.4 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.9 | 18.6 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.9 | 0.9 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.9 | 116.9 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.9 | 4.4 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.9 | 6.1 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.9 | 14.5 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.8 | 4.2 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.8 | 5.8 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.8 | 7.4 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.8 | 5.6 | PID IFNG PATHWAY | IFN-gamma pathway |
0.8 | 10.5 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.8 | 21.7 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.8 | 16.7 | PID FGF PATHWAY | FGF signaling pathway |
0.8 | 3.2 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.7 | 5.2 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.7 | 143.4 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.7 | 33.2 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.7 | 9.3 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.7 | 4.3 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.7 | 3.6 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.7 | 2.1 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.7 | 6.3 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.7 | 10.4 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.7 | 21.4 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.7 | 8.2 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.7 | 3.4 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.7 | 1.4 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.7 | 22.4 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.7 | 2.0 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.7 | 2.0 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.6 | 15.5 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.6 | 1.3 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.6 | 7.6 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.6 | 7.0 | PID ENDOTHELIN PATHWAY | Endothelins |
0.6 | 5.5 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.6 | 8.3 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.6 | 2.9 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.6 | 7.4 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.6 | 2.3 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.5 | 0.5 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.5 | 1.6 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.5 | 9.8 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.5 | 112.4 | NABA MATRISOME | Ensemble of genes encoding extracellular matrix and extracellular matrix-associated proteins |
0.5 | 5.0 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.5 | 4.2 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.4 | 4.5 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.4 | 5.7 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.4 | 12.8 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.4 | 2.5 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.4 | 3.4 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.4 | 0.4 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.4 | 5.4 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.4 | 14.3 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.4 | 8.1 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.4 | 0.8 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.4 | 5.1 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.4 | 3.4 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.4 | 0.8 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.4 | 0.4 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.4 | 3.7 | PID BMP PATHWAY | BMP receptor signaling |
0.4 | 1.8 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.4 | 0.7 | PID INSULIN PATHWAY | Insulin Pathway |
0.4 | 2.1 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.4 | 3.9 | PID AURORA A PATHWAY | Aurora A signaling |
0.3 | 1.4 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.3 | 3.1 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.3 | 0.7 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.3 | 4.7 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.3 | 7.0 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.3 | 4.0 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.3 | 20.9 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.3 | 7.0 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.3 | 1.9 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.3 | 7.9 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.3 | 0.3 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.3 | 7.8 | PID PLK1 PATHWAY | PLK1 signaling events |
0.3 | 0.9 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.3 | 3.8 | PID P73PATHWAY | p73 transcription factor network |
0.3 | 1.0 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.3 | 0.8 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.2 | 0.2 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.2 | 3.1 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.2 | 3.2 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.2 | 1.3 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.2 | 0.4 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.2 | 0.2 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.2 | 0.2 | PID REELIN PATHWAY | Reelin signaling pathway |
0.2 | 1.8 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.2 | 0.3 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.2 | 0.3 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.1 | 0.1 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.1 | 0.9 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 0.4 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.1 | 0.7 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.1 | 1.7 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.1 | 0.6 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.1 | 4.9 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.1 | 0.1 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.1 | 1.6 | PID NOTCH PATHWAY | Notch signaling pathway |
0.1 | 1.4 | PID ATM PATHWAY | ATM pathway |
0.1 | 0.2 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.1 | 0.1 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.0 | 0.6 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.0 | 0.6 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 0.0 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.0 | 0.1 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.0 | 0.0 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.0 | 0.0 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.0 | 0.0 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.3 | 121.4 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
4.5 | 45.1 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
4.1 | 94.0 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
3.6 | 46.2 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
3.1 | 67.9 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
2.9 | 31.6 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
2.7 | 145.2 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
2.7 | 29.5 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
2.6 | 28.1 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
2.3 | 18.2 | REACTOME OPSINS | Genes involved in Opsins |
2.2 | 29.0 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
2.2 | 2.2 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
2.1 | 8.4 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
1.9 | 31.6 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
1.8 | 18.4 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
1.8 | 20.2 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
1.7 | 27.8 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
1.7 | 24.1 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
1.7 | 23.4 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
1.7 | 5.0 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
1.7 | 36.4 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
1.5 | 34.8 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
1.5 | 144.6 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
1.5 | 3.0 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
1.4 | 2.9 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
1.4 | 9.9 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
1.4 | 5.6 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
1.4 | 1.4 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
1.3 | 18.3 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
1.3 | 14.0 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
1.3 | 19.0 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
1.2 | 32.1 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
1.2 | 10.6 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
1.2 | 7.0 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
1.2 | 10.4 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
1.1 | 21.8 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
1.1 | 12.2 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
1.1 | 10.9 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
1.1 | 30.5 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
1.1 | 23.2 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
1.0 | 6.2 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
1.0 | 10.6 | REACTOME P75NTR SIGNALS VIA NFKB | Genes involved in p75NTR signals via NF-kB |
1.0 | 5.8 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.9 | 5.6 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.9 | 17.7 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
0.9 | 9.2 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.9 | 0.9 | REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | Genes involved in Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
0.9 | 5.4 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
0.9 | 1.8 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.9 | 8.8 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.9 | 46.9 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.8 | 8.5 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.8 | 11.8 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.8 | 19.2 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.8 | 2.5 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.8 | 7.4 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.8 | 6.4 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.8 | 3.2 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.8 | 7.8 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.8 | 4.7 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.8 | 13.1 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.8 | 10.0 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.8 | 9.2 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.8 | 2.3 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.8 | 1.5 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.7 | 11.1 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.7 | 2.2 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.7 | 2.2 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.7 | 5.7 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.7 | 2.9 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.7 | 4.3 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.7 | 7.1 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.7 | 1.4 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.7 | 0.7 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.7 | 1.4 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
0.7 | 10.4 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.7 | 3.4 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.7 | 3.4 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.7 | 5.4 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.7 | 6.0 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.7 | 10.6 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.7 | 2.6 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.6 | 1.9 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.6 | 9.0 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.6 | 0.6 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.6 | 1.9 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.6 | 16.5 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.6 | 6.3 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.6 | 1.9 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.6 | 13.0 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.6 | 9.2 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.6 | 6.7 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.6 | 27.2 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.6 | 16.8 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.6 | 5.4 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.6 | 6.5 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.6 | 6.2 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.6 | 27.9 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.6 | 2.2 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.6 | 2.2 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.5 | 11.5 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.5 | 4.4 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.5 | 3.3 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.5 | 4.9 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.5 | 1.1 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.5 | 15.9 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.5 | 41.9 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.5 | 1.0 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.5 | 3.5 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
0.5 | 2.5 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.5 | 3.4 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.5 | 13.2 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.5 | 40.0 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.5 | 6.3 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.5 | 11.3 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
0.5 | 14.0 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.5 | 3.3 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.4 | 2.7 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.4 | 2.2 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
0.4 | 8.4 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.4 | 0.4 | REACTOME ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK | Genes involved in Energy dependent regulation of mTOR by LKB1-AMPK |
0.4 | 5.7 | REACTOME SIGNALING BY FGFR1 MUTANTS | Genes involved in Signaling by FGFR1 mutants |
0.4 | 3.1 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.4 | 7.8 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.4 | 4.9 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.4 | 0.4 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.4 | 5.7 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.4 | 2.0 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.4 | 16.3 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.4 | 0.4 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.4 | 2.0 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.4 | 7.8 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.4 | 17.3 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.4 | 1.5 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.4 | 15.8 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.4 | 4.1 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.4 | 1.8 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.4 | 35.5 | REACTOME GASTRIN CREB SIGNALLING PATHWAY VIA PKC AND MAPK | Genes involved in Gastrin-CREB signalling pathway via PKC and MAPK |
0.4 | 2.6 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.4 | 4.0 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.4 | 2.2 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.4 | 8.7 | REACTOME INTEGRATION OF ENERGY METABOLISM | Genes involved in Integration of energy metabolism |
0.4 | 7.2 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.4 | 1.1 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.3 | 4.2 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.3 | 2.4 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.3 | 6.7 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.3 | 2.0 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.3 | 0.7 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.3 | 14.7 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.3 | 4.1 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.3 | 4.4 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.3 | 5.3 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.3 | 2.1 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.3 | 2.9 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.3 | 11.7 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.3 | 1.1 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.3 | 4.1 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.3 | 1.1 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.3 | 2.7 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.3 | 1.1 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.3 | 2.1 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.3 | 0.3 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.3 | 1.1 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.3 | 5.4 | REACTOME MEIOSIS | Genes involved in Meiosis |
0.3 | 0.3 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.3 | 4.5 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.3 | 2.0 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.2 | 1.2 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.2 | 2.6 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
0.2 | 4.3 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.2 | 0.7 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.2 | 1.6 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.2 | 1.9 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.2 | 3.0 | REACTOME AUTODEGRADATION OF CDH1 BY CDH1 APC C | Genes involved in Autodegradation of Cdh1 by Cdh1:APC/C |
0.2 | 0.9 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.2 | 1.1 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.2 | 0.7 | REACTOME SIGNALLING BY NGF | Genes involved in Signalling by NGF |
0.2 | 2.2 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.2 | 0.4 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.2 | 0.6 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.2 | 0.2 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.2 | 1.8 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.2 | 10.7 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.2 | 0.6 | REACTOME POST NMDA RECEPTOR ACTIVATION EVENTS | Genes involved in Post NMDA receptor activation events |
0.2 | 3.0 | REACTOME HOST INTERACTIONS OF HIV FACTORS | Genes involved in Host Interactions of HIV factors |
0.2 | 0.9 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.2 | 0.6 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.2 | 1.7 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.2 | 0.4 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.2 | 2.1 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.2 | 1.2 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.2 | 0.2 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.2 | 1.9 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.2 | 0.7 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.2 | 10.7 | REACTOME DIABETES PATHWAYS | Genes involved in Diabetes pathways |
0.1 | 0.7 | REACTOME HEMOSTASIS | Genes involved in Hemostasis |
0.1 | 3.2 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.1 | 2.9 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.1 | 1.4 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.1 | 1.1 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.1 | 0.5 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.1 | 1.6 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.1 | 0.6 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.1 | 1.1 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.1 | 0.2 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.1 | 1.5 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.1 | 0.9 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.1 | 2.5 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.1 | 1.6 | REACTOME M G1 TRANSITION | Genes involved in M/G1 Transition |
0.1 | 0.2 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.1 | 1.5 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.1 | 4.7 | REACTOME MITOTIC M M G1 PHASES | Genes involved in Mitotic M-M/G1 phases |
0.1 | 0.4 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.1 | 0.2 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.1 | 0.3 | REACTOME ACETYLCHOLINE BINDING AND DOWNSTREAM EVENTS | Genes involved in Acetylcholine Binding And Downstream Events |
0.1 | 0.8 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.1 | 0.1 | REACTOME S PHASE | Genes involved in S Phase |
0.1 | 2.9 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.1 | 0.1 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.1 | 0.8 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.1 | 0.6 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.1 | 0.1 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.1 | 0.5 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.1 | 0.5 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.0 | 0.5 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.0 | 0.6 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.0 | 0.4 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.0 | 0.1 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.0 | 0.1 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.0 | 0.1 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.0 | 0.2 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.0 | 0.0 | REACTOME SIGNALING BY ILS | Genes involved in Signaling by Interleukins |
0.0 | 0.2 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |